<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02960438</url>
  </required_header>
  <id_info>
    <org_study_id>E6011-J081-201</org_study_id>
    <nct_id>NCT02960438</nct_id>
  </id_info>
  <brief_title>A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to Methotrexate</brief_title>
  <official_title>A Dose Response Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Methotrexate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eisai Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eisai Inc.</source>
  <brief_summary>
    <textblock>
      This study is a multicenter, randomized, double-blind, placebo-controlled, parallel-group&#xD;
      comparison study in rheumatoid arthritis participants inadequately responding to&#xD;
      methotrexate.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 20, 2016</start_date>
  <completion_date type="Actual">September 17, 2019</completion_date>
  <primary_completion_date type="Actual">February 28, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment Phase: Percentage of Participants Who Achieved an American College of Rheumatology 20 (ACR20) Response at Week 12 Based on Non-responder Imputation (NRI)</measure>
    <time_frame>Week 12</time_frame>
    <description>The ACR20 response was defined as if the following 3 criteria (ACR components) were met: Greater than or equal to (&gt;=) 20 percent (%) reduction from baseline in the tender joint count (TJC) in 68 joints (TJC68); &gt;=20% reduction from baseline in the swollen joint count (SJC) in 66 joints (SJC66); &gt;=20% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (visual analog scale [VAS]) , Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), Health Assessment Questionnaire disability index (HAQ-DI), and C-reactive protein (CRP).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment Phase: Percentage of Participants Who Achieved an ACR20 Response at Weeks 2, 4, 8, 16, 20 and 24 Based on NRI</measure>
    <time_frame>Weeks 2, 4, 8, 16, 20, and 24</time_frame>
    <description>The ACR20 response was defined as if the following 3 criteria (ACR components) were met: &gt;=20% reduction from baseline in the TJC in 68 joints (TJC68); &gt;=20% reduction from baseline in the SJC in 66 joints (SJC66); &gt;=20% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (VAS), Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), HAQ-DI, and CRP.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Phase: Percentage of Participants Who Achieved an ACR50 Response at Weeks 2, 4, 8, 16, 20 and 24 Based on NRI</measure>
    <time_frame>Weeks 2, 4, 8, 16, 20, and 24</time_frame>
    <description>The ACR50 response was defined as if the following 3 criteria (ACR components) were met: &gt;=50% reduction from baseline in the TJC in 68 joints (TJC68); &gt;=50% reduction from baseline in the SJC in 66 joints (SJC66); &gt;=50% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (VAS), Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), HAQ-DI, and CRP.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Phase: Percentage of Participants Who Achieved an ACR70 Response at Weeks 2, 4, 8, 16, 20 and 24 Based on NRI</measure>
    <time_frame>Weeks 2, 4, 8, 16, 20, and 24</time_frame>
    <description>The ACR70 response was defined as if the following 3 criteria (ACR components) were met: &gt;=70% reduction from baseline in the TJC in 68 joints (TJC68); &gt;=70% reduction from baseline in the SJC in 66 joints (SJC66); &gt;=70% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (VAS), Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), HAQ-DI, and CRP.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Tender Joint Counts (TJC) at Each Visit Based on Last Observation Carried Forward (LOCF)</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>A total of 68 joints were examined for tenderness by applying pressure to the joint line or by moving joints through their respective ranges of motion. Joints were examined for tenderness by applying pressure to the joint line or by moving joints through their respective ranges of motion. Tender joints were marked with tick or cross in corresponding frames of the Assessment Sheet for Tender Joint Counts. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Swollen Joint Counts (SJC) at Each Visit Based on LOCF</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>A total of 66 joints (minus 2 hip joints from evaluated tender joints) were examined for swollen joints. Swollen joints were marked with open circles in corresponding frames of the Assessment Sheet for Swollen Joint Counts. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Participant's Assessment of Pain Based on VAS Score at Each Visit Based on LOCF</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>Intensity and severity of pain associated with rheumatoid arthritis (RA) were indicated by the participant on a score sheet, Pain/disease activity assessments reported by the participant, by placing a mark on a 100 millimeter (mm) horizontal VAS. The scale ranged from 0-100 mm, where 0 indicated no disease activity (symptom free and no arthritis symptoms) and 100 represented maximum disease activity (maximum arthritis disease activity). Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Participant's Global Assessment of Disease Activity Based on VAS Score at Each Visit Based on LOCF</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>Participants were evaluated on their disease activity of RA, and entered the result on the score sheet, disease activity assessments reported by the participant, by placing a mark on a 100 mm horizontal VAS. The scale ranged from 0-100 mm, where 0 indicated no disease activity (symptom free and no arthritis symptoms) and 100 represented maximum disease activity (maximum arthritis disease activity). Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Physician's Global Assessment of Disease Activity Scale Based on VAS Score at Each Visit Based on LOCF</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>The Physician's Global Assessment of Disease Activity was recorded using the 100 mm horizontal VAS. Physician rated participant's RA disease activity on a scale ranged from 0-100 mm, where 0 indicated no disease activity (no arthritis) and 100 represented maximum disease activity (maximum arthritis). Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Health Assessment Questionnaire Disability Index (HAQ-DI) at Each Visit Based on LOCF</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>The degree of disability was self-evaluated by the participant using the HAQ-DI. The assessment was made based on the activities capable without any aids or devices. The 20-question instrument assessed the degree of difficulty a person had in accomplishing tasks in 8 functional areas (dressing, arising, eating, walking, hygiene, reaching, gripping, and activities of daily living). Responses in each functional area were scored from 0, indicated no difficulty, to 3, indicated inability to perform a task in that area. Overall score was computed as the sum of domain scores and divided by the number of domains answered. Total possible score range: 0-3 where 0 = least difficulty and 3 = extreme difficulty. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in C-reactive Protein (CRP) Values at Each Visit Based on LOCF</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>CRP of each participants was measured as a part of blood biochemical tests. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Erythrocyte Sedimentation Rate (ESR) Values at Each Visit Based on LOCF</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80,and 84</time_frame>
    <description>ESR were a type of blood test. An ESR was used to monitor the arthritis condition. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Disease Activity Score 28 (DAS28)-ESR Values at Each Visit Based on LOCF</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>The DAS28 index was a composite score of weighted components including tender joint counts of 28, swollen joint counts of 28, participant global assessment of disease activity score, and ESR value. Total score ranged between 0-10. A DAS28-ESR score of 5.1 or above = high disease activity, a value between 3.2 and 5.1 = moderate disease activity and value between 2.6 and 3.2 = low disease activity, value &lt;2.6 = disease remission. A positive change in score indicates worsening, and a negative change indicates improvement. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in DAS28-CRP Values at Each Visit Based on LOCF</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>The DAS28 index was a composite score of weighted components including tender joint counts of 28, swollen joint counts of 28, participant global assessment of disease activity score, and CRP value. Total score ranged between 0-10. A DAS28-CRP score of 5.1 or above = high disease activity, a value between 3.2 and 5.1 = moderate disease activity and value between 2.6 and 3.2 = low disease activity, value &lt;2.6 = disease remission. A positive change in score indicates worsening, and a negative change indicates improvement. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Simple Disease Activity Index (SDAI) Values at Each Visit Based on LOCF</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>The SDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-86. SDAI score of 26 or above = high disease activity, a value between 11 and 26 = moderate disease activity and value less than or equal to (&lt;=) 11 = low disease activity, value &lt;=33 = disease remission. Higher scores indicated higher disease activity. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Clinical Disease Activity Index (CDAI) Values at Each Visit Based on LOCF</measure>
    <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>The CDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-76. CDAI score of 22 or above = high disease activity, a value between 10 and 22 = moderate disease activity and value less than or equal to &lt;=10 = low disease activity, value &lt;=2.8 = disease remission. Higher scores indicated higher disease activity. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With a European League Against Rheumatism (EULAR) Good, Moderate or No Response Using DAS28-ESR at Each Visit Based on NRI</measure>
    <time_frame>Treatment Phase: Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>The Disease Activity Score Based on 28-joints Count based EULAR response criteria were used to measure individual response as none, good, and moderate, depending on the extent of change from baseline and the level of disease activity reached. Good responders: change from baseline &gt;1.2 with DAS28 &lt;=3.2; moderate responders: change from baseline &gt;1.2 with DAS28 &gt;3.2 to &lt;=5.1 or change from baseline &gt;0.6 to &lt;=1.2 with DAS28 &lt;=5.1; non-responders: change from baseline &lt;=0.6 or change from baseline &gt;0.6 and &lt;=1.2 with DAS28 &gt;5.1. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With a EULAR Good or Moderate Response Using DAS28-CRP at Each Visit Based on NRI</measure>
    <time_frame>Treatment Phase: Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>The Disease Activity Score Based on 28-joints Count based EULAR response criteria were used to measure individual response as none, good, and moderate, depending on the extent of change from baseline and the level of disease activity reached. Good responders: change from baseline &gt;1.2 with DAS28 &lt;=3.2; moderate responders: change from baseline &gt;1.2 with DAS28 &gt;3.2 to &lt;=5.1 or change from baseline &gt;0.6 to &lt;=1.2 with DAS28 &lt;=5.1; non-responders: change from baseline &lt;=0.6 or change from baseline &gt;0.6 and &lt;=1.2 with DAS28 &gt;5.1. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Achieved SDAI Remission at Each Visit Based on NRI</measure>
    <time_frame>Treatment Phase: Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, 84, 88, 92, 96, 100, and 104</time_frame>
    <description>The SDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-86. SDAI score of 26 or above = high disease activity, a value between 11 and 26 = moderate disease activity and value &lt;=11 = low disease activity. Higher scores indicated higher disease activity. SDAI Remission was defined as SDAI score &lt;=3.3. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Achieved CDAI Remission at Each Visit Based on NRI</measure>
    <time_frame>Treatment Phase: Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>The CDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-76. CDAI score of 22 or above = high disease activity, a value between 10 and 22 = moderate disease activity and value less than or equal to &lt;=10 = low disease activity. Higher scores indicated higher disease activity. CDAI Remission was defined as CDAI score &lt;=2.8. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Achieved Boolean Remission at Each Visit Based on NRI</measure>
    <time_frame>Treatment Phase: Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
    <description>Boolean remission criteria was defined as: tender joint count 68 &lt;=1; swollen joint count 68 &lt;=1; CRP &lt;=1 mg/dL; and disease activity assessments VAS (mm) by participants &lt;=1. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Modified Total Sharp Score (mTSS) at Each Visit Based on Observed Cases (OC)</measure>
    <time_frame>Treatment Phase: Baseline and Week 24; Extension Phase: Baseline, Weeks 24, 52, 76, and 104</time_frame>
    <description>The mTSS was a measure of change in joint health. X-rays of hands, wrists, and feet (including distal interphalangeal joints) were obtained. Totals for hands and feet for erosion scores (range 0 to 320) and joint space narrowing scores (range 0 to 208) were calculated and added to obtain the mTSS (range = 0 [normal] to 528 [maximal disease]). An increase in mTSS from Baseline represents disease progression and/or joint worsening; no progression was defined as a change of &lt;=0.5. Data reported for the Extension Phase from Baseline and Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">273</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>E6011 100 milligrams (mg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the Treatment Phase, E6011 100 mg will be subcutaneously administered at Weeks 0, 1, and 2, and then every 2 weeks up to Week 22. In the Extension Phase, E6011 200 mg will be subcutaneously administered every 2 weeks until Week 102.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>E6011 200 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the Treatment Phase, E6011 200 mg will be subcutaneously administered at Weeks 0, 1, and 2, and then every 2 weeks up to Week 22. In the Extension Phase, E6011 200 mg will be subcutaneously administered every 2 weeks until Week 102.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>E6011 400 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the Treatment Phase, E6011 400 mg will be subcutaneously administered at Weeks 0, 1, 2, 4, 6, 8, and 10, and then E6011 200 mg will be subcutaneously administered every 2 weeks up to Week 22. In the Extension Phase, E6011 200 mg will be subcutaneously administered every 2 weeks until Week 102.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In the Treatment Phase, placebo will be subcutaneously administered at Weeks 0, 1, and 2, and then every 2 weeks up to Week 22. In the Extension Phase, E6011 200 mg will be subcutaneously administered every 2 weeks until Week 102.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>E6011</intervention_name>
    <description>subcutaneous administration</description>
    <arm_group_label>E6011 100 milligrams (mg)</arm_group_label>
    <arm_group_label>E6011 200 mg</arm_group_label>
    <arm_group_label>E6011 400 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>subcutaneous administration</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Aged greater than or equal to (&gt;=) 18 and less than (&lt;)75 years old at the time of&#xD;
             informed consent&#xD;
&#xD;
          -  Diagnosed with rheumatoid arthritis (RA) under the 1987 American College of&#xD;
             Rheumatology (ACR) or 2010 ACR/European League Against Rheumatism (EULAR) criteria&#xD;
             &gt;=12 weeks before informed consent&#xD;
&#xD;
          -  Received methotrexate (MTX) treatment at 6 to 16 milligram (mg)/week for &gt;=12 weeks&#xD;
             before screening and presented ≥6 tender joints (out of 68 joints) and &gt;=6 swollen&#xD;
             joints (out of 66 joints) in the Screening and Observation Phases&#xD;
&#xD;
          -  Can continue stable dose regimen of MTX at 6 to 16 mg/week from 4 weeks before&#xD;
             starting the study treatment until completion of the Extension Phase (or until study&#xD;
             discontinuation)&#xD;
&#xD;
          -  C-reactive protein (CRP) level &gt;=0.6 mg/deciliter (dL) or erythrocyte sedimentation&#xD;
             rate (ESR) &gt;=28 millimeters per hour (mm/hr) in the Screening Phase&#xD;
&#xD;
          -  Erosions at &gt;=3 sites in radiographic image in the Screening Phase, or those with&#xD;
             erosions at &gt;=1 site and either positive for rheumatoid factor (RF) or anti-cyclic&#xD;
             citrullinated peptide (CCP) antibody in the Screening Phase&#xD;
&#xD;
          -  Weighs &gt;=30 kilograms (kg) and ≤100 kg in the Screening Phase&#xD;
&#xD;
          -  Has voluntarily consented, in writing, to participate in this study. If a participant&#xD;
             is below the age of 20, also consented, in writing, by a legally acceptable&#xD;
             representative.&#xD;
&#xD;
          -  Has been thoroughly briefed on the conditions for participation in the study, is able&#xD;
             to understand, and is willing and able to comply with all aspects of the protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any history or complication of inflammatory arthritic disorder other than RA or&#xD;
             Sjogren's syndrome&#xD;
&#xD;
          -  Meets the ACR 1991 Revised Criteria for the Classification of Global Functional Status&#xD;
             in RA Class IV in the Screening Phase&#xD;
&#xD;
          -  Received immunoglobulin preparations or blood products within 24 weeks before starting&#xD;
             the study treatment&#xD;
&#xD;
          -  Received a live vaccine within 12 weeks before starting the study treatment, or is&#xD;
             planning to receive&#xD;
&#xD;
          -  Evidence of clinically significant disease (example, cardiac, respiratory,&#xD;
             gastrointestinal, or renal disease) that could affect the participant's safety or&#xD;
             interfere with the study assessments in the opinion of the investigator or&#xD;
             subinvestigator&#xD;
&#xD;
          -  Complication of uncontrolled disorders such as acute cardiac infarction, unstable&#xD;
             angina, brain infarct, or symptomatic intracerebral hemorrhage&#xD;
&#xD;
          -  History of severe allergy (shock or anaphylactoid symptoms)&#xD;
&#xD;
          -  History or current clinical condition of malignant tumor, lymphoma, leukemia, or&#xD;
             lymphoproliferative disease, except for skin carcinoma (epithelial carcinoma or basal&#xD;
             cell carcinoma) and cervix carcinoma which has completely excised and without&#xD;
             metastasis or recurrence for more than 5 years before informed consent&#xD;
&#xD;
          -  Immunodeficiency or history of human immunodeficiency virus (HIV) infection&#xD;
&#xD;
          -  Infection requiring hospitalization or intravenous administration of antibiotics or&#xD;
             disease requiring administration of antivirus drugs (example, herpes zoster) within 4&#xD;
             weeks before starting the study treatment&#xD;
&#xD;
          -  History of tuberculosis or current complication of active tuberculosis&#xD;
&#xD;
          -  History of clinically important vasculitis&#xD;
&#xD;
          -  Tested positive for any of the following in the Screening Phase: HIV, hepatitis B&#xD;
             virus surface antigen (HBs antigen), hepatitis B virus surface antibody (HBs&#xD;
             antibody), hepatitis B virus core antibody (HBc antibody), hepatitis B virus&#xD;
             deoxyribonucleic acid (HBV DNA), hepatitis C virus antibody (HCV antibody), human&#xD;
             T-lymphotrophic virus Type I antibody (HTLV-1 antibody), or syphilis&#xD;
&#xD;
          -  Positive in tuberculosis test (QuantiFERON®TB Gold Test or T-SPOT®.TB Test) in the&#xD;
             Screening Phase&#xD;
&#xD;
          -  Findings indicating a history of tuberculosis on chest x-ray in the Screening Phase&#xD;
&#xD;
          -  Neurological findings such as paralysis, visual impairment, or language disorder in&#xD;
             the Screening Phase&#xD;
&#xD;
          -  Demonstrated prolonged QTcF interval (&gt;450 milliseconds [ms]) in repeated&#xD;
             electrocardiogram examinations&#xD;
&#xD;
          -  Females of childbearing potential who have a positive pregnancy test in the Screening&#xD;
             or Observation Phase or are breastfeeding&#xD;
&#xD;
          -  Females of childbearing potential who:&#xD;
&#xD;
               -  Had unprotected sexual intercourse within 30 days before study entry and who do&#xD;
                  not agree to use a highly effective method of contraception (e.g., total&#xD;
                  abstinence, an intrauterine device, a double-barrier method [such as condom plus&#xD;
                  diaphragm with spermicide], a contraceptive implant, an oral contraceptive, or&#xD;
                  have a vasectomized partner with confirmed azoospermia) throughout the entire&#xD;
                  study period or for 28 days after study drug discontinuation&#xD;
&#xD;
               -  Are currently abstinent, and do not agree to use a double-barrier method (as&#xD;
                  described above) or refrain from being sexually active during the study period or&#xD;
                  for 28 days after study drug discontinuation&#xD;
&#xD;
               -  Are using hormonal contraceptives but are not on a stable dose of the same&#xD;
                  hormonal contraceptive product for at least 4 weeks before dosing and who do not&#xD;
                  agree to use the same contraceptive during the study or for 28 days after study&#xD;
                  drug discontinuation (NOTE: All females will be considered to be of childbearing&#xD;
                  potential unless they are postmenopausal [amenorrheic for at least 12 consecutive&#xD;
                  months, in the appropriate age group, and without other known or suspected cause]&#xD;
                  or have been sterilized surgically [i.e., bilateral tubal ligation, total&#xD;
                  hysterectomy, or bilateral oophorectomy, all with surgery at least 1 month before&#xD;
                  dosing]).&#xD;
&#xD;
          -  Males who have not had a successful vasectomy (confirmed azoospermia) or they and&#xD;
             their female partners do not meet the criteria above (i.e., not of childbearing&#xD;
             potential or practicing highly effective contraception throughout the study period or&#xD;
             for 28 days after study drug discontinuation). No sperm donation is allowed during the&#xD;
             study period or for 28 days after study drug discontinuation.&#xD;
&#xD;
          -  Scheduled for surgery during the study&#xD;
&#xD;
          -  Currently enrolled in another clinical study or used any investigational drug or&#xD;
             device within 28 days (or 5* the half-life, whichever is longer) before informed&#xD;
             consent&#xD;
&#xD;
          -  Has been treated with E6011 or any biologics for use in RA that has not been approved&#xD;
&#xD;
          -  Use of a psychotropic agent as recreational purpose other than therapeutic purpose&#xD;
&#xD;
          -  Any history of a medical condition or a concomitant medical condition that in the&#xD;
             opinion of the investigator or subinvestigator would compromise the participant's&#xD;
             ability to safely complete the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #3</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #4</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Toyohashi</city>
        <state>Aichi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Toyota</city>
        <state>Aichi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Funabashi</city>
        <state>Chiba</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Matsuyama</city>
        <state>Ehime</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Iizuka</city>
        <state>Fukuoka</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Kitakyushu</city>
        <state>Fukuoka</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Kurume</city>
        <state>Fukuoka</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Kurume</city>
        <state>Fukuoka</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Takasaki</city>
        <state>Gunma</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Takasaki</city>
        <state>Gunma</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Asahikawa</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Hakodate</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Kushiro</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #3</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Tomakomai</city>
        <state>Hokkaido</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Takarazuka</city>
        <state>Hyogo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Hitachinaka</city>
        <state>Ibaraki</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Hitachi</city>
        <state>Ibaraki</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Kasama</city>
        <state>Ibaraki</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Komatsu</city>
        <state>Ishikawa</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Morioka</city>
        <state>Iwate</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Kirishima</city>
        <state>Kagoshima</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Yokohama</city>
        <state>Kanagawa</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Yokohama</city>
        <state>Kanagawa</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Yamaga</city>
        <state>Kumamoto</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Yokkaichi</city>
        <state>Mie</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Osaki</city>
        <state>Miyagi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Sendai</city>
        <state>Miyagi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Sendai</city>
        <state>Miyagi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Hyuga</city>
        <state>Miyazaki</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial site #2</name>
      <address>
        <city>Hyuga</city>
        <state>Miyazaki</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Matsumoto</city>
        <state>Nagano</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Isahaya</city>
        <state>Nagasaki</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Omura</city>
        <state>Nagasaki</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Sasebo</city>
        <state>Nagasaki</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Nagaoka</city>
        <state>Niigata</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Shibata</city>
        <state>Niigata</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Beppu</city>
        <state>Oita</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Tomigusuku</city>
        <state>Okinawa</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Kawachinagano</city>
        <state>Osaka</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Ureshino</city>
        <state>Saga</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Hiki</city>
        <state>Saitama</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Kawagoe</city>
        <state>Saitama</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Kawaguchi</city>
        <state>Saitama</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Tokorozawa</city>
        <state>Saitama</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Hamamatsu</city>
        <state>Shizuoka</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Shimotsuke</city>
        <state>Tochigi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Bunkyo</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Chuo</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Fuchu</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Itabashi</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Meguro</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Musashino</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Nakano</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Ome</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Ota</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Setagaya</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Shinjuku</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Shinjuku</city>
        <state>Tokyo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Takaoka</city>
        <state>Toyama</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Nishimuro</city>
        <state>Wakayama</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Shimonoseki</city>
        <state>Yamaguchi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Shimonoseki</city>
        <state>Yamaguchi</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Fukui</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Fukuoka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Gifu</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Hiroshima</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Hiroshima</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #3</name>
      <address>
        <city>Hiroshima</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Kagoshima</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Kagoshima</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #3</name>
      <address>
        <city>Kagoshima</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Kochi</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Kumamoto</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Miyagi</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Miyazaki</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Nagano</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Nagasaki</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #2</name>
      <address>
        <city>Nagasaki</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #3</name>
      <address>
        <city>Nagasaki</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Oita</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Saitama</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisai Trial Site #1</name>
      <address>
        <city>Shizuoka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>November 3, 2016</study_first_submitted>
  <study_first_submitted_qc>November 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2016</study_first_posted>
  <results_first_submitted>May 26, 2021</results_first_submitted>
  <results_first_submitted_qc>May 26, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 21, 2021</results_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>E6011</keyword>
  <keyword>rheumatoid arthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Quetmolimab</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 25, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT02960438/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan: Treatment Phase</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 19, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT02960438/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan: Extension Phase</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 24, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT02960438/SAP_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants took part in the study at 91 investigative sites in Japan from 20 October 2016 to 17 September 2019.</recruitment_details>
      <pre_assignment_details>A total of 273 participants were screened and enrolled (signed informed consent form), of which 79 were screen failures, and 194 were randomized out which 190 received study treatment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase and received E6011 200 milligram (mg), infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
        <group group_id="P2">
          <title>E6011 100 mg</title>
          <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
        <group group_id="P3">
          <title>E6011 200 mg</title>
          <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
        <group group_id="P4">
          <title>E6011 400/200 mg</title>
          <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Treatment Phase (Double-blind): 24 Weeks</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="29"/>
                <participants group_id="P3" count="54"/>
                <participants group_id="P4" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Treated Participants</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
                <participants group_id="P2" count="28"/>
                <participants group_id="P3" count="54"/>
                <participants group_id="P4" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="26"/>
                <participants group_id="P3" count="50"/>
                <participants group_id="P4" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Inadequate Therapeutic Effect</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Progression of Disease</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Not Treated</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Extension Phase (Open-label): 80 Weeks</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="26"/>
                <participants group_id="P3" count="50"/>
                <participants group_id="P4" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="36"/>
                <participants group_id="P4" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Inadequate Therapeutic Effect</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Progression of Disease</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Full analysis set (FAS) was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement.</population>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
        <group group_id="B2">
          <title>E6011 100 mg</title>
          <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
        <group group_id="B3">
          <title>E6011 200 mg</title>
          <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
        <group group_id="B4">
          <title>E6011 400/200 mg</title>
          <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="54"/>
            <count group_id="B2" value="28"/>
            <count group_id="B3" value="54"/>
            <count group_id="B4" value="54"/>
            <count group_id="B5" value="190"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.6" spread="9.86"/>
                    <measurement group_id="B2" value="56.5" spread="10.40"/>
                    <measurement group_id="B3" value="56.5" spread="10.39"/>
                    <measurement group_id="B4" value="55.2" spread="9.13"/>
                    <measurement group_id="B5" value="56.4" spread="9.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                    <measurement group_id="B4" value="39"/>
                    <measurement group_id="B5" value="150"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="54"/>
                    <measurement group_id="B4" value="54"/>
                    <measurement group_id="B5" value="190"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Japanese</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="54"/>
                    <measurement group_id="B4" value="54"/>
                    <measurement group_id="B5" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Treatment Phase: Percentage of Participants Who Achieved an American College of Rheumatology 20 (ACR20) Response at Week 12 Based on Non-responder Imputation (NRI)</title>
        <description>The ACR20 response was defined as if the following 3 criteria (ACR components) were met: Greater than or equal to (&gt;=) 20 percent (%) reduction from baseline in the tender joint count (TJC) in 68 joints (TJC68); &gt;=20% reduction from baseline in the swollen joint count (SJC) in 66 joints (SJC66); &gt;=20% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (visual analog scale [VAS]) , Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), Health Assessment Questionnaire disability index (HAQ-DI), and C-reactive protein (CRP).</description>
        <time_frame>Week 12</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Missing data was imputed using NRI and this Outcome Measure was planned to be assessed only in Treatment Phase.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Phase: Percentage of Participants Who Achieved an American College of Rheumatology 20 (ACR20) Response at Week 12 Based on Non-responder Imputation (NRI)</title>
          <description>The ACR20 response was defined as if the following 3 criteria (ACR components) were met: Greater than or equal to (&gt;=) 20 percent (%) reduction from baseline in the tender joint count (TJC) in 68 joints (TJC68); &gt;=20% reduction from baseline in the swollen joint count (SJC) in 66 joints (SJC66); &gt;=20% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (visual analog scale [VAS]) , Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), Health Assessment Questionnaire disability index (HAQ-DI), and C-reactive protein (CRP).</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Missing data was imputed using NRI and this Outcome Measure was planned to be assessed only in Treatment Phase.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.0" lower_limit="24.16" upper_limit="49.92"/>
                    <measurement group_id="O2" value="39.3" lower_limit="21.20" upper_limit="57.38"/>
                    <measurement group_id="O3" value="48.1" lower_limit="34.82" upper_limit="61.47"/>
                    <measurement group_id="O4" value="46.3" lower_limit="33.00" upper_limit="59.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.374</p_value>
            <method>Regression, Logistic</method>
            <param_type>Difference of arms</param_type>
            <param_value>2.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-19.96</ci_lower_limit>
            <ci_upper_limit>24.46</ci_upper_limit>
            <estimate_desc>Estimate was calculated based on the normal approximation to the binomial distribution.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.102</p_value>
            <method>Regression, Logistic</method>
            <param_type>Difference of arms</param_type>
            <param_value>11.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7.42</ci_lower_limit>
            <ci_upper_limit>29.64</ci_upper_limit>
            <estimate_desc>Estimate was calculated based on the normal approximation to the binomial distribution.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.188</p_value>
            <method>Regression, Logistic</method>
            <param_type>Difference of arms</param_type>
            <param_value>9.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.25</ci_lower_limit>
            <ci_upper_limit>27.77</ci_upper_limit>
            <estimate_desc>Estimate was calculated based on the normal approximation to the binomial distribution.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment Phase: Percentage of Participants Who Achieved an ACR20 Response at Weeks 2, 4, 8, 16, 20 and 24 Based on NRI</title>
        <description>The ACR20 response was defined as if the following 3 criteria (ACR components) were met: &gt;=20% reduction from baseline in the TJC in 68 joints (TJC68); &gt;=20% reduction from baseline in the SJC in 66 joints (SJC66); &gt;=20% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (VAS), Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), HAQ-DI, and CRP.</description>
        <time_frame>Weeks 2, 4, 8, 16, 20, and 24</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Missing data was imputed using NRI and this Outcome Measure was planned to be assessed only in Treatment Phase.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Phase: Percentage of Participants Who Achieved an ACR20 Response at Weeks 2, 4, 8, 16, 20 and 24 Based on NRI</title>
          <description>The ACR20 response was defined as if the following 3 criteria (ACR components) were met: &gt;=20% reduction from baseline in the TJC in 68 joints (TJC68); &gt;=20% reduction from baseline in the SJC in 66 joints (SJC66); &gt;=20% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (VAS), Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), HAQ-DI, and CRP.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Missing data was imputed using NRI and this Outcome Measure was planned to be assessed only in Treatment Phase.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Response at Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.0" lower_limit="4.00" upper_limit="21.92"/>
                    <measurement group_id="O2" value="14.3" lower_limit="1.32" upper_limit="27.25"/>
                    <measurement group_id="O3" value="22.2" lower_limit="11.13" upper_limit="33.31"/>
                    <measurement group_id="O4" value="20.4" lower_limit="9.63" upper_limit="31.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.5" lower_limit="8.16" upper_limit="28.88"/>
                    <measurement group_id="O2" value="28.6" lower_limit="11.84" upper_limit="45.30"/>
                    <measurement group_id="O3" value="24.1" lower_limit="12.67" upper_limit="35.48"/>
                    <measurement group_id="O4" value="31.5" lower_limit="19.09" upper_limit="43.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.7" lower_limit="27.64" upper_limit="53.85"/>
                    <measurement group_id="O2" value="35.7" lower_limit="17.97" upper_limit="53.46"/>
                    <measurement group_id="O3" value="37.0" lower_limit="24.16" upper_limit="49.92"/>
                    <measurement group_id="O4" value="46.3" lower_limit="33.00" upper_limit="59.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.3" lower_limit="33.00" upper_limit="59.60"/>
                    <measurement group_id="O2" value="46.4" lower_limit="27.96" upper_limit="64.90"/>
                    <measurement group_id="O3" value="51.9" lower_limit="38.53" upper_limit="65.18"/>
                    <measurement group_id="O4" value="53.7" lower_limit="40.40" upper_limit="67.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="20.76" upper_limit="45.91"/>
                    <measurement group_id="O2" value="50.0" lower_limit="31.48" upper_limit="68.52"/>
                    <measurement group_id="O3" value="59.3" lower_limit="46.15" upper_limit="72.36"/>
                    <measurement group_id="O4" value="55.6" lower_limit="42.30" upper_limit="68.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.2" lower_limit="22.45" upper_limit="47.92"/>
                    <measurement group_id="O2" value="39.3" lower_limit="21.20" upper_limit="57.38"/>
                    <measurement group_id="O3" value="53.7" lower_limit="40.40" upper_limit="67.00"/>
                    <measurement group_id="O4" value="57.4" lower_limit="44.22" upper_limit="70.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment Phase: Percentage of Participants Who Achieved an ACR50 Response at Weeks 2, 4, 8, 16, 20 and 24 Based on NRI</title>
        <description>The ACR50 response was defined as if the following 3 criteria (ACR components) were met: &gt;=50% reduction from baseline in the TJC in 68 joints (TJC68); &gt;=50% reduction from baseline in the SJC in 66 joints (SJC66); &gt;=50% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (VAS), Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), HAQ-DI, and CRP.</description>
        <time_frame>Weeks 2, 4, 8, 16, 20, and 24</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Missing data was imputed using NRI and this Outcome Measure was planned to be assessed only in Treatment Phase.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Phase: Percentage of Participants Who Achieved an ACR50 Response at Weeks 2, 4, 8, 16, 20 and 24 Based on NRI</title>
          <description>The ACR50 response was defined as if the following 3 criteria (ACR components) were met: &gt;=50% reduction from baseline in the TJC in 68 joints (TJC68); &gt;=50% reduction from baseline in the SJC in 66 joints (SJC66); &gt;=50% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (VAS), Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), HAQ-DI, and CRP.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Missing data was imputed using NRI and this Outcome Measure was planned to be assessed only in Treatment Phase.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Response at Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="7.4" lower_limit="0.42" upper_limit="14.39"/>
                    <measurement group_id="O4" value="7.4" lower_limit="0.42" upper_limit="14.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O2" value="3.6" lower_limit="0.00" upper_limit="10.45"/>
                    <measurement group_id="O3" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O4" value="9.3" lower_limit="1.53" upper_limit="16.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" lower_limit="0.42" upper_limit="14.39"/>
                    <measurement group_id="O2" value="14.3" lower_limit="1.32" upper_limit="27.25"/>
                    <measurement group_id="O3" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O4" value="9.3" lower_limit="1.53" upper_limit="16.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.8" lower_limit="5.34" upper_limit="24.29"/>
                    <measurement group_id="O2" value="10.7" lower_limit="0.00" upper_limit="22.17"/>
                    <measurement group_id="O3" value="25.9" lower_limit="14.24" upper_limit="37.61"/>
                    <measurement group_id="O4" value="18.5" lower_limit="8.16" upper_limit="28.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.8" lower_limit="5.34" upper_limit="24.29"/>
                    <measurement group_id="O2" value="17.9" lower_limit="3.67" upper_limit="32.04"/>
                    <measurement group_id="O3" value="20.4" lower_limit="9.63" upper_limit="31.11"/>
                    <measurement group_id="O4" value="22.2" lower_limit="11.13" upper_limit="33.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.8" lower_limit="5.34" upper_limit="24.29"/>
                    <measurement group_id="O2" value="10.7" lower_limit="0.00" upper_limit="22.17"/>
                    <measurement group_id="O3" value="31.5" lower_limit="19.09" upper_limit="43.87"/>
                    <measurement group_id="O4" value="25.9" lower_limit="14.24" upper_limit="37.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7" lower_limit="6.73" upper_limit="26.61"/>
                    <measurement group_id="O2" value="17.9" lower_limit="3.67" upper_limit="32.04"/>
                    <measurement group_id="O3" value="25.9" lower_limit="14.24" upper_limit="37.61"/>
                    <measurement group_id="O4" value="27.8" lower_limit="15.83" upper_limit="39.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment Phase: Percentage of Participants Who Achieved an ACR70 Response at Weeks 2, 4, 8, 16, 20 and 24 Based on NRI</title>
        <description>The ACR70 response was defined as if the following 3 criteria (ACR components) were met: &gt;=70% reduction from baseline in the TJC in 68 joints (TJC68); &gt;=70% reduction from baseline in the SJC in 66 joints (SJC66); &gt;=70% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (VAS), Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), HAQ-DI, and CRP.</description>
        <time_frame>Weeks 2, 4, 8, 16, 20, and 24</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Missing data was imputed using NRI and this Outcome Measure was planned to be assessed only in Treatment Phase.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Phase: Percentage of Participants Who Achieved an ACR70 Response at Weeks 2, 4, 8, 16, 20 and 24 Based on NRI</title>
          <description>The ACR70 response was defined as if the following 3 criteria (ACR components) were met: &gt;=70% reduction from baseline in the TJC in 68 joints (TJC68); &gt;=70% reduction from baseline in the SJC in 66 joints (SJC66); &gt;=70% reduction from baseline in at least 3 of the following 5 assessments: Physician's Global Assessment of Disease Activity (VAS), Participant's Global Assessment of Disease Activity (VAS), Participant's Assessment of Pain (VAS), HAQ-DI, and CRP.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Missing data was imputed using NRI and this Outcome Measure was planned to be assessed only in Treatment Phase.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Response at Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O4" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O4" value="5.6" lower_limit="0.00" upper_limit="11.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O2" value="3.6" lower_limit="0.00" upper_limit="10.45"/>
                    <measurement group_id="O3" value="9.3" lower_limit="1.53" upper_limit="16.99"/>
                    <measurement group_id="O4" value="7.4" lower_limit="0.42" upper_limit="14.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" lower_limit="0.00" upper_limit="11.67"/>
                    <measurement group_id="O2" value="7.1" lower_limit="0.00" upper_limit="16.68"/>
                    <measurement group_id="O3" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O4" value="13.0" lower_limit="4.00" upper_limit="21.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" lower_limit="0.00" upper_limit="11.67"/>
                    <measurement group_id="O2" value="7.1" lower_limit="0.00" upper_limit="16.68"/>
                    <measurement group_id="O3" value="11.1" lower_limit="2.73" upper_limit="19.49"/>
                    <measurement group_id="O4" value="14.8" lower_limit="5.34" upper_limit="24.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Response at Week 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" lower_limit="0.00" upper_limit="11.67"/>
                    <measurement group_id="O2" value="14.3" lower_limit="1.32" upper_limit="27.25"/>
                    <measurement group_id="O3" value="11.1" lower_limit="2.73" upper_limit="19.49"/>
                    <measurement group_id="O4" value="13.0" lower_limit="4.00" upper_limit="21.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Tender Joint Counts (TJC) at Each Visit Based on Last Observation Carried Forward (LOCF)</title>
        <description>A total of 68 joints were examined for tenderness by applying pressure to the joint line or by moving joints through their respective ranges of motion. Joints were examined for tenderness by applying pressure to the joint line or by moving joints through their respective ranges of motion. Tender joints were marked with tick or cross in corresponding frames of the Assessment Sheet for Tender Joint Counts. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Tender Joint Counts (TJC) at Each Visit Based on Last Observation Carried Forward (LOCF)</title>
          <description>A total of 68 joints were examined for tenderness by applying pressure to the joint line or by moving joints through their respective ranges of motion. Joints were examined for tenderness by applying pressure to the joint line or by moving joints through their respective ranges of motion. Tender joints were marked with tick or cross in corresponding frames of the Assessment Sheet for Tender Joint Counts. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>tender joints</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.7" spread="6.81"/>
                    <measurement group_id="O2" value="14.1" spread="7.24"/>
                    <measurement group_id="O3" value="16.3" spread="7.15"/>
                    <measurement group_id="O4" value="16.6" spread="9.61"/>
                    <measurement group_id="O5" value="13.6" spread="6.72"/>
                    <measurement group_id="O6" value="14.3" spread="7.49"/>
                    <measurement group_id="O7" value="15.7" spread="6.70"/>
                    <measurement group_id="O8" value="16.6" spread="9.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.9" spread="5.63"/>
                    <measurement group_id="O2" value="-2.7" spread="5.05"/>
                    <measurement group_id="O3" value="-3.6" spread="5.99"/>
                    <measurement group_id="O4" value="-3.9" spread="6.00"/>
                    <measurement group_id="O5" value="-3.2" spread="4.88"/>
                    <measurement group_id="O6" value="-2.5" spread="5.01"/>
                    <measurement group_id="O7" value="-3.4" spread="5.99"/>
                    <measurement group_id="O8" value="-4.5" spread="6.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.9" spread="6.04"/>
                    <measurement group_id="O2" value="-2.9" spread="4.47"/>
                    <measurement group_id="O3" value="-4.5" spread="5.34"/>
                    <measurement group_id="O4" value="-5.8" spread="7.68"/>
                    <measurement group_id="O5" value="-3.0" spread="5.63"/>
                    <measurement group_id="O6" value="-2.8" spread="4.44"/>
                    <measurement group_id="O7" value="-4.5" spread="5.29"/>
                    <measurement group_id="O8" value="-6.7" spread="7.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.9" spread="7.00"/>
                    <measurement group_id="O2" value="-4.6" spread="5.55"/>
                    <measurement group_id="O3" value="-5.7" spread="6.14"/>
                    <measurement group_id="O4" value="-6.7" spread="9.30"/>
                    <measurement group_id="O5" value="-4.7" spread="6.12"/>
                    <measurement group_id="O6" value="-4.6" spread="5.36"/>
                    <measurement group_id="O7" value="-5.7" spread="5.98"/>
                    <measurement group_id="O8" value="-7.6" spread="9.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.2" spread="7.40"/>
                    <measurement group_id="O2" value="-5.2" spread="6.83"/>
                    <measurement group_id="O3" value="-7.1" spread="7.42"/>
                    <measurement group_id="O4" value="-7.9" spread="9.77"/>
                    <measurement group_id="O5" value="-5.0" spread="6.54"/>
                    <measurement group_id="O6" value="-5.3" spread="6.83"/>
                    <measurement group_id="O7" value="-7.3" spread="7.18"/>
                    <measurement group_id="O8" value="-8.9" spread="10.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.3" spread="7.51"/>
                    <measurement group_id="O2" value="-6.4" spread="7.34"/>
                    <measurement group_id="O3" value="-8.4" spread="6.53"/>
                    <measurement group_id="O4" value="-7.9" spread="10.33"/>
                    <measurement group_id="O5" value="-6.3" spread="6.53"/>
                    <measurement group_id="O6" value="-6.6" spread="7.36"/>
                    <measurement group_id="O7" value="-8.6" spread="6.20"/>
                    <measurement group_id="O8" value="-9.3" spread="9.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.6" spread="8.50"/>
                    <measurement group_id="O2" value="-6.9" spread="7.33"/>
                    <measurement group_id="O3" value="-7.6" spread="7.72"/>
                    <measurement group_id="O4" value="-8.5" spread="9.68"/>
                    <measurement group_id="O5" value="-6.8" spread="7.70"/>
                    <measurement group_id="O6" value="-7.2" spread="7.31"/>
                    <measurement group_id="O7" value="-7.8" spread="7.59"/>
                    <measurement group_id="O8" value="-10.0" spread="9.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.6" spread="7.97"/>
                    <measurement group_id="O2" value="-6.9" spread="7.55"/>
                    <measurement group_id="O3" value="-8.6" spread="7.38"/>
                    <measurement group_id="O4" value="-8.7" spread="9.93"/>
                    <measurement group_id="O5" value="-6.8" spread="7.02"/>
                    <measurement group_id="O6" value="-7.2" spread="7.55"/>
                    <measurement group_id="O7" value="-8.9" spread="7.13"/>
                    <measurement group_id="O8" value="-10.4" spread="9.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.6" spread="7.85"/>
                    <measurement group_id="O6" value="-7.5" spread="7.40"/>
                    <measurement group_id="O7" value="-9.5" spread="7.74"/>
                    <measurement group_id="O8" value="-10.1" spread="9.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-8.4" spread="7.94"/>
                    <measurement group_id="O6" value="-7.9" spread="7.00"/>
                    <measurement group_id="O7" value="-8.6" spread="7.94"/>
                    <measurement group_id="O8" value="-10.0" spread="9.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-8.1" spread="9.25"/>
                    <measurement group_id="O6" value="-7.6" spread="6.86"/>
                    <measurement group_id="O7" value="-9.4" spread="6.85"/>
                    <measurement group_id="O8" value="-11.3" spread="10.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-8.3" spread="8.98"/>
                    <measurement group_id="O6" value="-7.5" spread="6.59"/>
                    <measurement group_id="O7" value="-9.9" spread="6.79"/>
                    <measurement group_id="O8" value="-10.7" spread="9.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.5" spread="8.12"/>
                    <measurement group_id="O6" value="-7.4" spread="6.33"/>
                    <measurement group_id="O7" value="-9.9" spread="7.53"/>
                    <measurement group_id="O8" value="-11.4" spread="10.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.3" spread="9.30"/>
                    <measurement group_id="O6" value="-8.2" spread="6.59"/>
                    <measurement group_id="O7" value="-9.4" spread="7.98"/>
                    <measurement group_id="O8" value="-10.9" spread="10.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.6" spread="7.90"/>
                    <measurement group_id="O6" value="-8.0" spread="6.68"/>
                    <measurement group_id="O7" value="-10.2" spread="6.44"/>
                    <measurement group_id="O8" value="-10.7" spread="9.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.9" spread="7.65"/>
                    <measurement group_id="O6" value="-7.7" spread="6.71"/>
                    <measurement group_id="O7" value="-9.1" spread="7.62"/>
                    <measurement group_id="O8" value="-11.0" spread="8.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-8.0" spread="8.03"/>
                    <measurement group_id="O6" value="-8.4" spread="6.24"/>
                    <measurement group_id="O7" value="-10.0" spread="8.14"/>
                    <measurement group_id="O8" value="-11.5" spread="9.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-8.4" spread="8.70"/>
                    <measurement group_id="O6" value="-8.7" spread="6.24"/>
                    <measurement group_id="O7" value="-9.0" spread="7.86"/>
                    <measurement group_id="O8" value="-12.1" spread="8.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-8.5" spread="8.15"/>
                    <measurement group_id="O6" value="-7.5" spread="6.84"/>
                    <measurement group_id="O7" value="-9.7" spread="8.45"/>
                    <measurement group_id="O8" value="-12.0" spread="9.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-8.3" spread="8.23"/>
                    <measurement group_id="O6" value="-7.9" spread="6.39"/>
                    <measurement group_id="O7" value="-9.8" spread="7.80"/>
                    <measurement group_id="O8" value="-11.2" spread="10.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-8.2" spread="8.12"/>
                    <measurement group_id="O6" value="-8.2" spread="6.63"/>
                    <measurement group_id="O7" value="-10.5" spread="7.88"/>
                    <measurement group_id="O8" value="-11.8" spread="9.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-8.2" spread="8.29"/>
                    <measurement group_id="O6" value="-8.5" spread="6.37"/>
                    <measurement group_id="O7" value="-10.5" spread="7.77"/>
                    <measurement group_id="O8" value="-11.8" spread="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-8.2" spread="8.08"/>
                    <measurement group_id="O6" value="-8.0" spread="6.26"/>
                    <measurement group_id="O7" value="-10.5" spread="7.79"/>
                    <measurement group_id="O8" value="-11.7" spread="9.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Swollen Joint Counts (SJC) at Each Visit Based on LOCF</title>
        <description>A total of 66 joints (minus 2 hip joints from evaluated tender joints) were examined for swollen joints. Swollen joints were marked with open circles in corresponding frames of the Assessment Sheet for Swollen Joint Counts. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Swollen Joint Counts (SJC) at Each Visit Based on LOCF</title>
          <description>A total of 66 joints (minus 2 hip joints from evaluated tender joints) were examined for swollen joints. Swollen joints were marked with open circles in corresponding frames of the Assessment Sheet for Swollen Joint Counts. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>swollen joints</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.7" spread="6.81"/>
                    <measurement group_id="O2" value="11.3" spread="5.27"/>
                    <measurement group_id="O3" value="12.4" spread="4.89"/>
                    <measurement group_id="O4" value="13.5" spread="6.41"/>
                    <measurement group_id="O5" value="12.7" spread="6.48"/>
                    <measurement group_id="O6" value="11.5" spread="5.38"/>
                    <measurement group_id="O7" value="12.1" spread="4.63"/>
                    <measurement group_id="O8" value="13.8" spread="6.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.2" spread="4.70"/>
                    <measurement group_id="O2" value="-2.8" spread="3.33"/>
                    <measurement group_id="O3" value="-2.9" spread="4.18"/>
                    <measurement group_id="O4" value="-3.4" spread="5.25"/>
                    <measurement group_id="O5" value="-2.9" spread="4.21"/>
                    <measurement group_id="O6" value="-2.9" spread="3.46"/>
                    <measurement group_id="O7" value="-3.0" spread="3.84"/>
                    <measurement group_id="O8" value="-3.7" spread="5.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.0" spread="5.36"/>
                    <measurement group_id="O2" value="-3.7" spread="3.42"/>
                    <measurement group_id="O3" value="-3.3" spread="4.66"/>
                    <measurement group_id="O4" value="-5.0" spread="4.95"/>
                    <measurement group_id="O5" value="-3.8" spread="3.94"/>
                    <measurement group_id="O6" value="-3.8" spread="3.51"/>
                    <measurement group_id="O7" value="-3.5" spread="4.03"/>
                    <measurement group_id="O8" value="-5.5" spread="5.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.1" spread="7.33"/>
                    <measurement group_id="O2" value="-4.7" spread="4.16"/>
                    <measurement group_id="O3" value="-3.8" spread="5.82"/>
                    <measurement group_id="O4" value="-6.0" spread="5.81"/>
                    <measurement group_id="O5" value="-5.7" spread="4.70"/>
                    <measurement group_id="O6" value="-4.7" spread="4.32"/>
                    <measurement group_id="O7" value="-3.8" spread="5.42"/>
                    <measurement group_id="O8" value="-6.7" spread="5.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.2" spread="7.05"/>
                    <measurement group_id="O2" value="-5.1" spread="4.91"/>
                    <measurement group_id="O3" value="-4.9" spread="5.39"/>
                    <measurement group_id="O4" value="-5.7" spread="6.41"/>
                    <measurement group_id="O5" value="-5.9" spread="4.11"/>
                    <measurement group_id="O6" value="-5.2" spread="5.08"/>
                    <measurement group_id="O7" value="-5.2" spread="4.93"/>
                    <measurement group_id="O8" value="-6.4" spread="6.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.3" spread="7.38"/>
                    <measurement group_id="O2" value="-6.1" spread="4.32"/>
                    <measurement group_id="O3" value="-5.2" spread="5.30"/>
                    <measurement group_id="O4" value="-6.6" spread="6.60"/>
                    <measurement group_id="O5" value="-6.0" spread="4.65"/>
                    <measurement group_id="O6" value="-6.3" spread="4.43"/>
                    <measurement group_id="O7" value="-5.5" spread="4.81"/>
                    <measurement group_id="O8" value="-8.0" spread="5.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.1" spread="8.73"/>
                    <measurement group_id="O2" value="-6.4" spread="4.65"/>
                    <measurement group_id="O3" value="-5.6" spread="5.71"/>
                    <measurement group_id="O4" value="-6.4" spread="7.26"/>
                    <measurement group_id="O5" value="-7.0" spread="6.50"/>
                    <measurement group_id="O6" value="-6.6" spread="4.78"/>
                    <measurement group_id="O7" value="-5.8" spread="5.28"/>
                    <measurement group_id="O8" value="-7.7" spread="6.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.1" spread="8.32"/>
                    <measurement group_id="O2" value="-6.3" spread="4.28"/>
                    <measurement group_id="O3" value="-5.9" spread="6.38"/>
                    <measurement group_id="O4" value="-6.2" spread="6.65"/>
                    <measurement group_id="O5" value="-7.0" spread="5.86"/>
                    <measurement group_id="O6" value="-6.5" spread="4.38"/>
                    <measurement group_id="O7" value="-6.2" spread="5.93"/>
                    <measurement group_id="O8" value="-7.6" spread="5.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.2" spread="6.77"/>
                    <measurement group_id="O6" value="-7.8" spread="5.05"/>
                    <measurement group_id="O7" value="-6.9" spread="5.71"/>
                    <measurement group_id="O8" value="-8.5" spread="5.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.9" spread="7.04"/>
                    <measurement group_id="O6" value="-7.6" spread="4.63"/>
                    <measurement group_id="O7" value="-7.0" spread="6.17"/>
                    <measurement group_id="O8" value="-8.6" spread="6.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.2" spread="7.52"/>
                    <measurement group_id="O6" value="-7.5" spread="4.64"/>
                    <measurement group_id="O7" value="-7.1" spread="5.90"/>
                    <measurement group_id="O8" value="-9.0" spread="5.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.4" spread="7.55"/>
                    <measurement group_id="O6" value="-7.2" spread="4.43"/>
                    <measurement group_id="O7" value="-6.8" spread="5.10"/>
                    <measurement group_id="O8" value="-8.4" spread="5.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-6.9" spread="7.75"/>
                    <measurement group_id="O6" value="-6.5" spread="4.54"/>
                    <measurement group_id="O7" value="-6.8" spread="5.44"/>
                    <measurement group_id="O8" value="-8.3" spread="6.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.2" spread="8.04"/>
                    <measurement group_id="O6" value="-6.7" spread="4.48"/>
                    <measurement group_id="O7" value="-6.4" spread="6.11"/>
                    <measurement group_id="O8" value="-8.5" spread="5.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.2" spread="7.19"/>
                    <measurement group_id="O6" value="-6.7" spread="4.54"/>
                    <measurement group_id="O7" value="-6.3" spread="5.03"/>
                    <measurement group_id="O8" value="-8.3" spread="5.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.3" spread="7.18"/>
                    <measurement group_id="O6" value="-7.0" spread="3.77"/>
                    <measurement group_id="O7" value="-6.3" spread="5.89"/>
                    <measurement group_id="O8" value="-8.6" spread="5.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.4" spread="6.83"/>
                    <measurement group_id="O6" value="-7.3" spread="4.32"/>
                    <measurement group_id="O7" value="-6.5" spread="6.40"/>
                    <measurement group_id="O8" value="-8.5" spread="6.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.5" spread="7.67"/>
                    <measurement group_id="O6" value="-7.3" spread="4.61"/>
                    <measurement group_id="O7" value="-6.4" spread="6.21"/>
                    <measurement group_id="O8" value="-8.5" spread="5.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-8.0" spread="7.30"/>
                    <measurement group_id="O6" value="-6.5" spread="5.21"/>
                    <measurement group_id="O7" value="-6.9" spread="5.79"/>
                    <measurement group_id="O8" value="-8.6" spread="5.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.9" spread="7.49"/>
                    <measurement group_id="O6" value="-7.0" spread="4.76"/>
                    <measurement group_id="O7" value="-6.9" spread="5.93"/>
                    <measurement group_id="O8" value="-8.8" spread="5.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.7" spread="7.21"/>
                    <measurement group_id="O6" value="-6.3" spread="4.77"/>
                    <measurement group_id="O7" value="-7.1" spread="5.81"/>
                    <measurement group_id="O8" value="-8.3" spread="5.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.2" spread="7.50"/>
                    <measurement group_id="O6" value="-7.1" spread="4.89"/>
                    <measurement group_id="O7" value="-6.7" spread="6.18"/>
                    <measurement group_id="O8" value="-8.4" spread="6.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-7.7" spread="7.38"/>
                    <measurement group_id="O6" value="-7.2" spread="4.92"/>
                    <measurement group_id="O7" value="-6.9" spread="6.08"/>
                    <measurement group_id="O8" value="-8.2" spread="6.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Participant's Assessment of Pain Based on VAS Score at Each Visit Based on LOCF</title>
        <description>Intensity and severity of pain associated with rheumatoid arthritis (RA) were indicated by the participant on a score sheet, Pain/disease activity assessments reported by the participant, by placing a mark on a 100 millimeter (mm) horizontal VAS. The scale ranged from 0-100 mm, where 0 indicated no disease activity (symptom free and no arthritis symptoms) and 100 represented maximum disease activity (maximum arthritis disease activity). Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Participant's Assessment of Pain Based on VAS Score at Each Visit Based on LOCF</title>
          <description>Intensity and severity of pain associated with rheumatoid arthritis (RA) were indicated by the participant on a score sheet, Pain/disease activity assessments reported by the participant, by placing a mark on a 100 millimeter (mm) horizontal VAS. The scale ranged from 0-100 mm, where 0 indicated no disease activity (symptom free and no arthritis symptoms) and 100 represented maximum disease activity (maximum arthritis disease activity). Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.6" spread="23.03"/>
                    <measurement group_id="O2" value="47.9" spread="26.37"/>
                    <measurement group_id="O3" value="46.6" spread="23.03"/>
                    <measurement group_id="O4" value="52.9" spread="24.38"/>
                    <measurement group_id="O5" value="54.2" spread="21.89"/>
                    <measurement group_id="O6" value="46.6" spread="26.94"/>
                    <measurement group_id="O7" value="46.7" spread="22.95"/>
                    <measurement group_id="O8" value="49.6" spread="24.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.0" spread="17.96"/>
                    <measurement group_id="O2" value="-4.5" spread="12.64"/>
                    <measurement group_id="O3" value="-6.2" spread="17.22"/>
                    <measurement group_id="O4" value="-5.9" spread="16.91"/>
                    <measurement group_id="O5" value="-5.2" spread="18.88"/>
                    <measurement group_id="O6" value="-4.4" spread="13.08"/>
                    <measurement group_id="O7" value="-6.4" spread="17.81"/>
                    <measurement group_id="O8" value="-5.1" spread="17.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.8" spread="22.47"/>
                    <measurement group_id="O2" value="-6.4" spread="20.68"/>
                    <measurement group_id="O3" value="-4.1" spread="18.36"/>
                    <measurement group_id="O4" value="-9.0" spread="18.93"/>
                    <measurement group_id="O5" value="-9.0" spread="21.34"/>
                    <measurement group_id="O6" value="-6.6" spread="21.47"/>
                    <measurement group_id="O7" value="-4.4" spread="18.77"/>
                    <measurement group_id="O8" value="-8.3" spread="19.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.8" spread="20.76"/>
                    <measurement group_id="O2" value="-4.9" spread="19.96"/>
                    <measurement group_id="O3" value="-10.0" spread="18.29"/>
                    <measurement group_id="O4" value="-16.6" spread="22.58"/>
                    <measurement group_id="O5" value="-10.5" spread="18.73"/>
                    <measurement group_id="O6" value="-5.7" spread="20.51"/>
                    <measurement group_id="O7" value="-11.0" spread="18.45"/>
                    <measurement group_id="O8" value="-17.0" spread="23.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.5" spread="26.09"/>
                    <measurement group_id="O2" value="-12.2" spread="18.19"/>
                    <measurement group_id="O3" value="-12.9" spread="21.24"/>
                    <measurement group_id="O4" value="-13.7" spread="25.24"/>
                    <measurement group_id="O5" value="-11.0" spread="25.10"/>
                    <measurement group_id="O6" value="-12.8" spread="18.75"/>
                    <measurement group_id="O7" value="-14.6" spread="20.72"/>
                    <measurement group_id="O8" value="-15.2" spread="26.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.8" spread="27.25"/>
                    <measurement group_id="O2" value="-11.4" spread="19.69"/>
                    <measurement group_id="O3" value="-13.6" spread="20.87"/>
                    <measurement group_id="O4" value="-15.1" spread="25.78"/>
                    <measurement group_id="O5" value="-14.1" spread="26.26"/>
                    <measurement group_id="O6" value="-11.7" spread="20.42"/>
                    <measurement group_id="O7" value="-14.8" spread="20.91"/>
                    <measurement group_id="O8" value="-17.8" spread="26.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.1" spread="29.43"/>
                    <measurement group_id="O2" value="-13.5" spread="19.33"/>
                    <measurement group_id="O3" value="-15.0" spread="21.08"/>
                    <measurement group_id="O4" value="-16.6" spread="26.04"/>
                    <measurement group_id="O5" value="-12.9" spread="28.35"/>
                    <measurement group_id="O6" value="-14.4" spread="19.75"/>
                    <measurement group_id="O7" value="-16.6" spread="20.67"/>
                    <measurement group_id="O8" value="-19.3" spread="26.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.4" spread="28.49"/>
                    <measurement group_id="O2" value="-13.9" spread="21.59"/>
                    <measurement group_id="O3" value="-14.4" spread="20.85"/>
                    <measurement group_id="O4" value="-18.5" spread="24.29"/>
                    <measurement group_id="O5" value="-13.2" spread="27.17"/>
                    <measurement group_id="O6" value="-14.8" spread="22.11"/>
                    <measurement group_id="O7" value="-16.0" spread="20.47"/>
                    <measurement group_id="O8" value="-21.6" spread="24.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-18.0" spread="26.34"/>
                    <measurement group_id="O6" value="-12.9" spread="25.13"/>
                    <measurement group_id="O7" value="-14.0" spread="22.45"/>
                    <measurement group_id="O8" value="-22.3" spread="27.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-17.9" spread="27.27"/>
                    <measurement group_id="O6" value="-16.9" spread="23.06"/>
                    <measurement group_id="O7" value="-14.6" spread="22.57"/>
                    <measurement group_id="O8" value="-21.0" spread="33.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-15.5" spread="28.89"/>
                    <measurement group_id="O6" value="-14.4" spread="23.58"/>
                    <measurement group_id="O7" value="-16.8" spread="25.04"/>
                    <measurement group_id="O8" value="-22.2" spread="31.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-15.3" spread="28.08"/>
                    <measurement group_id="O6" value="-15.5" spread="23.14"/>
                    <measurement group_id="O7" value="-17.7" spread="23.93"/>
                    <measurement group_id="O8" value="-22.7" spread="29.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-16.7" spread="26.93"/>
                    <measurement group_id="O6" value="-17.8" spread="21.77"/>
                    <measurement group_id="O7" value="-17.5" spread="23.27"/>
                    <measurement group_id="O8" value="-23.1" spread="29.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-20.0" spread="27.74"/>
                    <measurement group_id="O6" value="-17.6" spread="24.36"/>
                    <measurement group_id="O7" value="-17.6" spread="22.50"/>
                    <measurement group_id="O8" value="-23.4" spread="28.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-17.2" spread="28.24"/>
                    <measurement group_id="O6" value="-15.3" spread="25.63"/>
                    <measurement group_id="O7" value="-16.9" spread="25.39"/>
                    <measurement group_id="O8" value="-22.7" spread="24.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-20.8" spread="27.88"/>
                    <measurement group_id="O6" value="-16.0" spread="25.02"/>
                    <measurement group_id="O7" value="-18.7" spread="22.74"/>
                    <measurement group_id="O8" value="-21.8" spread="24.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-22.6" spread="28.21"/>
                    <measurement group_id="O6" value="-16.2" spread="23.69"/>
                    <measurement group_id="O7" value="-18.0" spread="23.76"/>
                    <measurement group_id="O8" value="-24.6" spread="26.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-21.2" spread="26.46"/>
                    <measurement group_id="O6" value="-16.1" spread="24.34"/>
                    <measurement group_id="O7" value="-17.5" spread="26.63"/>
                    <measurement group_id="O8" value="-22.0" spread="26.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-24.6" spread="27.59"/>
                    <measurement group_id="O6" value="-17.7" spread="25.96"/>
                    <measurement group_id="O7" value="-16.2" spread="25.65"/>
                    <measurement group_id="O8" value="-24.1" spread="27.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-23.3" spread="27.81"/>
                    <measurement group_id="O6" value="-16.7" spread="24.96"/>
                    <measurement group_id="O7" value="-16.2" spread="25.49"/>
                    <measurement group_id="O8" value="-24.5" spread="27.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-21.4" spread="27.70"/>
                    <measurement group_id="O6" value="-19.0" spread="26.29"/>
                    <measurement group_id="O7" value="-16.9" spread="25.92"/>
                    <measurement group_id="O8" value="-24.2" spread="28.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-21.4" spread="29.20"/>
                    <measurement group_id="O6" value="-19.3" spread="25.29"/>
                    <measurement group_id="O7" value="-16.2" spread="25.09"/>
                    <measurement group_id="O8" value="-24.8" spread="25.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-23.2" spread="28.58"/>
                    <measurement group_id="O6" value="-18.3" spread="26.01"/>
                    <measurement group_id="O7" value="-17.1" spread="24.50"/>
                    <measurement group_id="O8" value="-24.4" spread="27.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Participant's Global Assessment of Disease Activity Based on VAS Score at Each Visit Based on LOCF</title>
        <description>Participants were evaluated on their disease activity of RA, and entered the result on the score sheet, disease activity assessments reported by the participant, by placing a mark on a 100 mm horizontal VAS. The scale ranged from 0-100 mm, where 0 indicated no disease activity (symptom free and no arthritis symptoms) and 100 represented maximum disease activity (maximum arthritis disease activity). Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Participant's Global Assessment of Disease Activity Based on VAS Score at Each Visit Based on LOCF</title>
          <description>Participants were evaluated on their disease activity of RA, and entered the result on the score sheet, disease activity assessments reported by the participant, by placing a mark on a 100 mm horizontal VAS. The scale ranged from 0-100 mm, where 0 indicated no disease activity (symptom free and no arthritis symptoms) and 100 represented maximum disease activity (maximum arthritis disease activity). Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.1" spread="25.74"/>
                    <measurement group_id="O2" value="50.1" spread="25.04"/>
                    <measurement group_id="O3" value="49.0" spread="22.37"/>
                    <measurement group_id="O4" value="54.5" spread="23.97"/>
                    <measurement group_id="O5" value="53.4" spread="25.30"/>
                    <measurement group_id="O6" value="49.2" spread="25.77"/>
                    <measurement group_id="O7" value="49.2" spread="22.19"/>
                    <measurement group_id="O8" value="51.3" spread="23.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.9" spread="20.03"/>
                    <measurement group_id="O2" value="-4.2" spread="14.32"/>
                    <measurement group_id="O3" value="-8.3" spread="17.32"/>
                    <measurement group_id="O4" value="-6.4" spread="16.40"/>
                    <measurement group_id="O5" value="-3.8" spread="21.28"/>
                    <measurement group_id="O6" value="-4.5" spread="14.70"/>
                    <measurement group_id="O7" value="-8.5" spread="17.84"/>
                    <measurement group_id="O8" value="-5.5" spread="16.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.4" spread="24.49"/>
                    <measurement group_id="O2" value="-6.6" spread="17.03"/>
                    <measurement group_id="O3" value="-7.2" spread="16.29"/>
                    <measurement group_id="O4" value="-9.8" spread="19.73"/>
                    <measurement group_id="O5" value="-9.4" spread="23.96"/>
                    <measurement group_id="O6" value="-7.0" spread="17.50"/>
                    <measurement group_id="O7" value="-7.6" spread="16.64"/>
                    <measurement group_id="O8" value="-9.5" spread="20.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.5" spread="23.48"/>
                    <measurement group_id="O2" value="-7.3" spread="18.62"/>
                    <measurement group_id="O3" value="-11.6" spread="18.67"/>
                    <measurement group_id="O4" value="-18.1" spread="23.66"/>
                    <measurement group_id="O5" value="-7.5" spread="22.61"/>
                    <measurement group_id="O6" value="-8.5" spread="18.82"/>
                    <measurement group_id="O7" value="-12.8" spread="18.80"/>
                    <measurement group_id="O8" value="-18.8" spread="24.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.3" spread="27.83"/>
                    <measurement group_id="O2" value="-14.6" spread="18.22"/>
                    <measurement group_id="O3" value="-15.2" spread="18.50"/>
                    <measurement group_id="O4" value="-15.1" spread="27.23"/>
                    <measurement group_id="O5" value="-10.0" spread="27.59"/>
                    <measurement group_id="O6" value="-15.8" spread="18.36"/>
                    <measurement group_id="O7" value="-17.0" spread="17.62"/>
                    <measurement group_id="O8" value="-17.3" spread="28.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.6" spread="27.40"/>
                    <measurement group_id="O2" value="-14.0" spread="20.19"/>
                    <measurement group_id="O3" value="-16.1" spread="20.49"/>
                    <measurement group_id="O4" value="-16.6" spread="27.22"/>
                    <measurement group_id="O5" value="-14.7" spread="26.47"/>
                    <measurement group_id="O6" value="-15.3" spread="20.31"/>
                    <measurement group_id="O7" value="-17.4" spread="20.46"/>
                    <measurement group_id="O8" value="-19.3" spread="28.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.0" spread="30.67"/>
                    <measurement group_id="O2" value="-15.3" spread="19.24"/>
                    <measurement group_id="O3" value="-17.4" spread="21.43"/>
                    <measurement group_id="O4" value="-17.8" spread="28.14"/>
                    <measurement group_id="O5" value="-13.6" spread="29.69"/>
                    <measurement group_id="O6" value="-17.0" spread="18.89"/>
                    <measurement group_id="O7" value="-19.2" spread="21.03"/>
                    <measurement group_id="O8" value="-20.7" spread="29.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.8" spread="30.97"/>
                    <measurement group_id="O2" value="-15.3" spread="23.29"/>
                    <measurement group_id="O3" value="-17.8" spread="20.27"/>
                    <measurement group_id="O4" value="-20.4" spread="24.90"/>
                    <measurement group_id="O5" value="-12.3" spread="30.20"/>
                    <measurement group_id="O6" value="-17.0" spread="23.30"/>
                    <measurement group_id="O7" value="-19.6" spread="19.72"/>
                    <measurement group_id="O8" value="-23.8" spread="25.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-17.1" spread="30.18"/>
                    <measurement group_id="O6" value="-17.0" spread="24.50"/>
                    <measurement group_id="O7" value="-18.5" spread="21.28"/>
                    <measurement group_id="O8" value="-24.8" spread="27.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-19.3" spread="29.27"/>
                    <measurement group_id="O6" value="-19.8" spread="20.81"/>
                    <measurement group_id="O7" value="-16.7" spread="24.64"/>
                    <measurement group_id="O8" value="-23.2" spread="32.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-15.7" spread="28.40"/>
                    <measurement group_id="O6" value="-17.0" spread="22.63"/>
                    <measurement group_id="O7" value="-19.6" spread="24.05"/>
                    <measurement group_id="O8" value="-24.2" spread="31.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-15.8" spread="30.76"/>
                    <measurement group_id="O6" value="-18.6" spread="21.01"/>
                    <measurement group_id="O7" value="-20.4" spread="23.40"/>
                    <measurement group_id="O8" value="-24.6" spread="29.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-16.9" spread="27.20"/>
                    <measurement group_id="O6" value="-20.3" spread="20.23"/>
                    <measurement group_id="O7" value="-20.2" spread="23.05"/>
                    <measurement group_id="O8" value="-25.0" spread="29.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-18.5" spread="28.84"/>
                    <measurement group_id="O6" value="-19.6" spread="22.90"/>
                    <measurement group_id="O7" value="-20.3" spread="20.80"/>
                    <measurement group_id="O8" value="-24.8" spread="29.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-16.1" spread="31.20"/>
                    <measurement group_id="O6" value="-17.0" spread="23.15"/>
                    <measurement group_id="O7" value="-19.4" spread="23.97"/>
                    <measurement group_id="O8" value="-24.6" spread="25.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-20.0" spread="29.52"/>
                    <measurement group_id="O6" value="-18.0" spread="23.09"/>
                    <measurement group_id="O7" value="-20.3" spread="21.95"/>
                    <measurement group_id="O8" value="-25.2" spread="27.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-21.3" spread="28.76"/>
                    <measurement group_id="O6" value="-19.0" spread="21.14"/>
                    <measurement group_id="O7" value="-20.8" spread="23.05"/>
                    <measurement group_id="O8" value="-26.3" spread="27.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-20.1" spread="27.01"/>
                    <measurement group_id="O6" value="-19.1" spread="23.63"/>
                    <measurement group_id="O7" value="-19.9" spread="24.04"/>
                    <measurement group_id="O8" value="-24.5" spread="27.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-22.9" spread="28.89"/>
                    <measurement group_id="O6" value="-19.5" spread="25.09"/>
                    <measurement group_id="O7" value="-18.6" spread="24.69"/>
                    <measurement group_id="O8" value="-26.9" spread="28.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-21.7" spread="31.19"/>
                    <measurement group_id="O6" value="-19.0" spread="24.98"/>
                    <measurement group_id="O7" value="-18.6" spread="25.14"/>
                    <measurement group_id="O8" value="-26.4" spread="28.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-21.3" spread="29.79"/>
                    <measurement group_id="O6" value="-20.9" spread="24.88"/>
                    <measurement group_id="O7" value="-20.3" spread="25.11"/>
                    <measurement group_id="O8" value="-26.2" spread="28.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-21.0" spread="30.98"/>
                    <measurement group_id="O6" value="-20.4" spread="24.23"/>
                    <measurement group_id="O7" value="-19.2" spread="23.56"/>
                    <measurement group_id="O8" value="-27.3" spread="27.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-21.1" spread="31.62"/>
                    <measurement group_id="O6" value="-19.6" spread="24.67"/>
                    <measurement group_id="O7" value="-19.6" spread="22.45"/>
                    <measurement group_id="O8" value="-27.0" spread="28.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Physician's Global Assessment of Disease Activity Scale Based on VAS Score at Each Visit Based on LOCF</title>
        <description>The Physician's Global Assessment of Disease Activity was recorded using the 100 mm horizontal VAS. Physician rated participant's RA disease activity on a scale ranged from 0-100 mm, where 0 indicated no disease activity (no arthritis) and 100 represented maximum disease activity (maximum arthritis). Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Physician's Global Assessment of Disease Activity Scale Based on VAS Score at Each Visit Based on LOCF</title>
          <description>The Physician's Global Assessment of Disease Activity was recorded using the 100 mm horizontal VAS. Physician rated participant's RA disease activity on a scale ranged from 0-100 mm, where 0 indicated no disease activity (no arthritis) and 100 represented maximum disease activity (maximum arthritis). Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.3" spread="19.07"/>
                    <measurement group_id="O2" value="53.1" spread="21.88"/>
                    <measurement group_id="O3" value="55.2" spread="17.27"/>
                    <measurement group_id="O4" value="54.2" spread="22.02"/>
                    <measurement group_id="O5" value="53.7" spread="19.17"/>
                    <measurement group_id="O6" value="52.0" spread="22.20"/>
                    <measurement group_id="O7" value="54.2" spread="17.30"/>
                    <measurement group_id="O8" value="53.9" spread="21.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.1" spread="15.95"/>
                    <measurement group_id="O2" value="-9.5" spread="16.32"/>
                    <measurement group_id="O3" value="-11.1" spread="15.59"/>
                    <measurement group_id="O4" value="-7.9" spread="16.61"/>
                    <measurement group_id="O5" value="-10.4" spread="14.73"/>
                    <measurement group_id="O6" value="-7.3" spread="14.59"/>
                    <measurement group_id="O7" value="-10.3" spread="15.78"/>
                    <measurement group_id="O8" value="-8.1" spread="17.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.4" spread="16.83"/>
                    <measurement group_id="O2" value="-7.6" spread="14.11"/>
                    <measurement group_id="O3" value="-15.2" spread="16.36"/>
                    <measurement group_id="O4" value="-13.2" spread="20.76"/>
                    <measurement group_id="O5" value="-9.9" spread="15.99"/>
                    <measurement group_id="O6" value="-6.7" spread="13.23"/>
                    <measurement group_id="O7" value="-15.0" spread="16.68"/>
                    <measurement group_id="O8" value="-13.8" spread="21.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-13.6" spread="21.08"/>
                    <measurement group_id="O2" value="-11.3" spread="16.87"/>
                    <measurement group_id="O3" value="-16.6" spread="20.75"/>
                    <measurement group_id="O4" value="-16.1" spread="21.51"/>
                    <measurement group_id="O5" value="-15.5" spread="17.70"/>
                    <measurement group_id="O6" value="-9.3" spread="15.25"/>
                    <measurement group_id="O7" value="-16.7" spread="21.00"/>
                    <measurement group_id="O8" value="-19.0" spread="21.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.9" spread="24.14"/>
                    <measurement group_id="O2" value="-16.9" spread="24.74"/>
                    <measurement group_id="O3" value="-21.6" spread="18.54"/>
                    <measurement group_id="O4" value="-18.1" spread="26.27"/>
                    <measurement group_id="O5" value="-17.1" spread="21.36"/>
                    <measurement group_id="O6" value="-16.8" spread="25.04"/>
                    <measurement group_id="O7" value="-22.3" spread="17.53"/>
                    <measurement group_id="O8" value="-19.5" spread="26.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-16.1" spread="23.49"/>
                    <measurement group_id="O2" value="-19.3" spread="20.88"/>
                    <measurement group_id="O3" value="-23.1" spread="20.21"/>
                    <measurement group_id="O4" value="-19.3" spread="25.83"/>
                    <measurement group_id="O5" value="-19.1" spread="21.49"/>
                    <measurement group_id="O6" value="-19.3" spread="20.91"/>
                    <measurement group_id="O7" value="-23.6" spread="20.00"/>
                    <measurement group_id="O8" value="-23.7" spread="23.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-15.3" spread="25.97"/>
                    <measurement group_id="O2" value="-20.0" spread="21.27"/>
                    <measurement group_id="O3" value="-22.7" spread="20.32"/>
                    <measurement group_id="O4" value="-18.9" spread="28.39"/>
                    <measurement group_id="O5" value="-18.8" spread="24.20"/>
                    <measurement group_id="O6" value="-20.9" spread="21.65"/>
                    <measurement group_id="O7" value="-23.3" spread="19.81"/>
                    <measurement group_id="O8" value="-23.1" spread="27.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-15.5" spread="26.23"/>
                    <measurement group_id="O2" value="-17.8" spread="24.33"/>
                    <measurement group_id="O3" value="-24.6" spread="21.38"/>
                    <measurement group_id="O4" value="-20.8" spread="27.39"/>
                    <measurement group_id="O5" value="-19.0" spread="24.49"/>
                    <measurement group_id="O6" value="-18.4" spread="24.96"/>
                    <measurement group_id="O7" value="-25.4" spread="20.91"/>
                    <measurement group_id="O8" value="-25.7" spread="25.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-24.4" spread="22.28"/>
                    <measurement group_id="O6" value="-20.1" spread="24.68"/>
                    <measurement group_id="O7" value="-28.1" spread="19.69"/>
                    <measurement group_id="O8" value="-27.4" spread="26.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-25.9" spread="25.28"/>
                    <measurement group_id="O6" value="-21.7" spread="26.24"/>
                    <measurement group_id="O7" value="-24.4" spread="21.13"/>
                    <measurement group_id="O8" value="-25.9" spread="26.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-23.9" spread="25.96"/>
                    <measurement group_id="O6" value="-19.3" spread="23.02"/>
                    <measurement group_id="O7" value="-25.3" spread="20.46"/>
                    <measurement group_id="O8" value="-29.2" spread="27.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-25.2" spread="26.39"/>
                    <measurement group_id="O6" value="-22.7" spread="25.52"/>
                    <measurement group_id="O7" value="-27.8" spread="16.77"/>
                    <measurement group_id="O8" value="-27.0" spread="27.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-25.8" spread="28.22"/>
                    <measurement group_id="O6" value="-19.8" spread="22.76"/>
                    <measurement group_id="O7" value="-27.6" spread="19.34"/>
                    <measurement group_id="O8" value="-29.2" spread="28.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-27.3" spread="29.35"/>
                    <measurement group_id="O6" value="-21.6" spread="25.58"/>
                    <measurement group_id="O7" value="-27.8" spread="20.44"/>
                    <measurement group_id="O8" value="-26.9" spread="29.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-23.3" spread="28.22"/>
                    <measurement group_id="O6" value="-19.9" spread="24.81"/>
                    <measurement group_id="O7" value="-26.7" spread="20.55"/>
                    <measurement group_id="O8" value="-26.8" spread="28.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-23.6" spread="25.87"/>
                    <measurement group_id="O6" value="-20.8" spread="24.91"/>
                    <measurement group_id="O7" value="-26.8" spread="19.72"/>
                    <measurement group_id="O8" value="-28.2" spread="26.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-23.9" spread="28.72"/>
                    <measurement group_id="O6" value="-21.1" spread="23.93"/>
                    <measurement group_id="O7" value="-27.0" spread="21.24"/>
                    <measurement group_id="O8" value="-29.7" spread="26.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-26.4" spread="28.15"/>
                    <measurement group_id="O6" value="-20.1" spread="22.32"/>
                    <measurement group_id="O7" value="-24.9" spread="21.16"/>
                    <measurement group_id="O8" value="-29.4" spread="25.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-27.9" spread="27.73"/>
                    <measurement group_id="O6" value="-21.6" spread="26.92"/>
                    <measurement group_id="O7" value="-27.4" spread="21.10"/>
                    <measurement group_id="O8" value="-30.3" spread="27.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-25.0" spread="28.10"/>
                    <measurement group_id="O6" value="-20.2" spread="22.55"/>
                    <measurement group_id="O7" value="-27.1" spread="22.45"/>
                    <measurement group_id="O8" value="-29.0" spread="25.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-23.5" spread="28.17"/>
                    <measurement group_id="O6" value="-22.4" spread="22.89"/>
                    <measurement group_id="O7" value="-27.6" spread="21.89"/>
                    <measurement group_id="O8" value="-31.2" spread="26.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-24.0" spread="28.33"/>
                    <measurement group_id="O6" value="-24.9" spread="26.05"/>
                    <measurement group_id="O7" value="-26.9" spread="21.29"/>
                    <measurement group_id="O8" value="-31.5" spread="25.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-25.9" spread="28.47"/>
                    <measurement group_id="O6" value="-21.8" spread="24.09"/>
                    <measurement group_id="O7" value="-27.3" spread="20.49"/>
                    <measurement group_id="O8" value="-30.1" spread="25.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Health Assessment Questionnaire Disability Index (HAQ-DI) at Each Visit Based on LOCF</title>
        <description>The degree of disability was self-evaluated by the participant using the HAQ-DI. The assessment was made based on the activities capable without any aids or devices. The 20-question instrument assessed the degree of difficulty a person had in accomplishing tasks in 8 functional areas (dressing, arising, eating, walking, hygiene, reaching, gripping, and activities of daily living). Responses in each functional area were scored from 0, indicated no difficulty, to 3, indicated inability to perform a task in that area. Overall score was computed as the sum of domain scores and divided by the number of domains answered. Total possible score range: 0-3 where 0 = least difficulty and 3 = extreme difficulty. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Health Assessment Questionnaire Disability Index (HAQ-DI) at Each Visit Based on LOCF</title>
          <description>The degree of disability was self-evaluated by the participant using the HAQ-DI. The assessment was made based on the activities capable without any aids or devices. The 20-question instrument assessed the degree of difficulty a person had in accomplishing tasks in 8 functional areas (dressing, arising, eating, walking, hygiene, reaching, gripping, and activities of daily living). Responses in each functional area were scored from 0, indicated no difficulty, to 3, indicated inability to perform a task in that area. Overall score was computed as the sum of domain scores and divided by the number of domains answered. Total possible score range: 0-3 where 0 = least difficulty and 3 = extreme difficulty. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.77" spread="0.526"/>
                    <measurement group_id="O2" value="0.73" spread="0.527"/>
                    <measurement group_id="O3" value="0.75" spread="0.602"/>
                    <measurement group_id="O4" value="0.80" spread="0.611"/>
                    <measurement group_id="O5" value="0.75" spread="0.519"/>
                    <measurement group_id="O6" value="0.72" spread="0.541"/>
                    <measurement group_id="O7" value="0.74" spread="0.618"/>
                    <measurement group_id="O8" value="0.71" spread="0.543"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.281"/>
                    <measurement group_id="O2" value="-0.01" spread="0.236"/>
                    <measurement group_id="O3" value="-0.06" spread="0.295"/>
                    <measurement group_id="O4" value="-0.06" spread="0.301"/>
                    <measurement group_id="O5" value="-0.03" spread="0.223"/>
                    <measurement group_id="O6" value="0.00" spread="0.240"/>
                    <measurement group_id="O7" value="-0.05" spread="0.297"/>
                    <measurement group_id="O8" value="-0.05" spread="0.306"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.352"/>
                    <measurement group_id="O2" value="0.01" spread="0.277"/>
                    <measurement group_id="O3" value="-0.07" spread="0.299"/>
                    <measurement group_id="O4" value="-0.10" spread="0.303"/>
                    <measurement group_id="O5" value="-0.02" spread="0.265"/>
                    <measurement group_id="O6" value="0.03" spread="0.281"/>
                    <measurement group_id="O7" value="-0.06" spread="0.301"/>
                    <measurement group_id="O8" value="-0.12" spread="0.304"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.432"/>
                    <measurement group_id="O2" value="-0.03" spread="0.298"/>
                    <measurement group_id="O3" value="-0.10" spread="0.323"/>
                    <measurement group_id="O4" value="-0.12" spread="0.329"/>
                    <measurement group_id="O5" value="-0.03" spread="0.379"/>
                    <measurement group_id="O6" value="-0.03" spread="0.296"/>
                    <measurement group_id="O7" value="-0.08" spread="0.319"/>
                    <measurement group_id="O8" value="-0.13" spread="0.350"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.493"/>
                    <measurement group_id="O2" value="-0.06" spread="0.356"/>
                    <measurement group_id="O3" value="-0.13" spread="0.321"/>
                    <measurement group_id="O4" value="-0.14" spread="0.402"/>
                    <measurement group_id="O5" value="-0.02" spread="0.463"/>
                    <measurement group_id="O6" value="-0.04" spread="0.351"/>
                    <measurement group_id="O7" value="-0.11" spread="0.321"/>
                    <measurement group_id="O8" value="-0.16" spread="0.422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.469"/>
                    <measurement group_id="O2" value="-0.08" spread="0.330"/>
                    <measurement group_id="O3" value="-0.19" spread="0.330"/>
                    <measurement group_id="O4" value="-0.13" spread="0.411"/>
                    <measurement group_id="O5" value="-0.06" spread="0.434"/>
                    <measurement group_id="O6" value="-0.06" spread="0.315"/>
                    <measurement group_id="O7" value="-0.18" spread="0.332"/>
                    <measurement group_id="O8" value="-0.15" spread="0.433"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.519"/>
                    <measurement group_id="O2" value="-0.10" spread="0.285"/>
                    <measurement group_id="O3" value="-0.17" spread="0.335"/>
                    <measurement group_id="O4" value="-0.14" spread="0.435"/>
                    <measurement group_id="O5" value="-0.03" spread="0.485"/>
                    <measurement group_id="O6" value="-0.09" spread="0.285"/>
                    <measurement group_id="O7" value="-0.17" spread="0.337"/>
                    <measurement group_id="O8" value="-0.16" spread="0.461"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.494"/>
                    <measurement group_id="O2" value="-0.09" spread="0.300"/>
                    <measurement group_id="O3" value="-0.17" spread="0.337"/>
                    <measurement group_id="O4" value="-0.17" spread="0.446"/>
                    <measurement group_id="O5" value="-0.07" spread="0.450"/>
                    <measurement group_id="O6" value="-0.08" spread="0.300"/>
                    <measurement group_id="O7" value="-0.16" spread="0.339"/>
                    <measurement group_id="O8" value="-0.20" spread="0.470"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.07" spread="0.523"/>
                    <measurement group_id="O6" value="-0.09" spread="0.278"/>
                    <measurement group_id="O7" value="-0.21" spread="0.407"/>
                    <measurement group_id="O8" value="-0.23" spread="0.479"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.11" spread="0.544"/>
                    <measurement group_id="O6" value="-0.13" spread="0.314"/>
                    <measurement group_id="O7" value="-0.18" spread="0.392"/>
                    <measurement group_id="O8" value="-0.10" spread="0.670"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.05" spread="0.547"/>
                    <measurement group_id="O6" value="-0.06" spread="0.396"/>
                    <measurement group_id="O7" value="-0.20" spread="0.381"/>
                    <measurement group_id="O8" value="-0.17" spread="0.614"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.05" spread="0.531"/>
                    <measurement group_id="O6" value="-0.08" spread="0.337"/>
                    <measurement group_id="O7" value="-0.17" spread="0.318"/>
                    <measurement group_id="O8" value="-0.19" spread="0.594"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.10" spread="0.544"/>
                    <measurement group_id="O6" value="-0.11" spread="0.380"/>
                    <measurement group_id="O7" value="-0.19" spread="0.415"/>
                    <measurement group_id="O8" value="-0.19" spread="0.561"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.08" spread="0.546"/>
                    <measurement group_id="O6" value="-0.06" spread="0.366"/>
                    <measurement group_id="O7" value="-0.20" spread="0.434"/>
                    <measurement group_id="O8" value="-0.20" spread="0.592"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.06" spread="0.535"/>
                    <measurement group_id="O6" value="-0.04" spread="0.318"/>
                    <measurement group_id="O7" value="-0.22" spread="0.385"/>
                    <measurement group_id="O8" value="-0.19" spread="0.549"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.09" spread="0.525"/>
                    <measurement group_id="O6" value="-0.06" spread="0.303"/>
                    <measurement group_id="O7" value="-0.20" spread="0.425"/>
                    <measurement group_id="O8" value="-0.20" spread="0.539"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.10" spread="0.551"/>
                    <measurement group_id="O6" value="-0.09" spread="0.297"/>
                    <measurement group_id="O7" value="-0.19" spread="0.422"/>
                    <measurement group_id="O8" value="-0.24" spread="0.567"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.09" spread="0.518"/>
                    <measurement group_id="O6" value="-0.06" spread="0.366"/>
                    <measurement group_id="O7" value="-0.13" spread="0.457"/>
                    <measurement group_id="O8" value="-0.25" spread="0.591"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.13" spread="0.559"/>
                    <measurement group_id="O6" value="-0.09" spread="0.356"/>
                    <measurement group_id="O7" value="-0.16" spread="0.508"/>
                    <measurement group_id="O8" value="-0.24" spread="0.597"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.17" spread="0.542"/>
                    <measurement group_id="O6" value="-0.06" spread="0.357"/>
                    <measurement group_id="O7" value="-0.19" spread="0.500"/>
                    <measurement group_id="O8" value="-0.23" spread="0.596"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.16" spread="0.557"/>
                    <measurement group_id="O6" value="-0.11" spread="0.309"/>
                    <measurement group_id="O7" value="-0.18" spread="0.475"/>
                    <measurement group_id="O8" value="-0.26" spread="0.602"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.11" spread="0.555"/>
                    <measurement group_id="O6" value="-0.12" spread="0.325"/>
                    <measurement group_id="O7" value="-0.16" spread="0.514"/>
                    <measurement group_id="O8" value="-0.25" spread="0.579"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.15" spread="0.567"/>
                    <measurement group_id="O6" value="-0.08" spread="0.332"/>
                    <measurement group_id="O7" value="-0.19" spread="0.467"/>
                    <measurement group_id="O8" value="-0.25" spread="0.586"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in C-reactive Protein (CRP) Values at Each Visit Based on LOCF</title>
        <description>CRP of each participants was measured as a part of blood biochemical tests. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in C-reactive Protein (CRP) Values at Each Visit Based on LOCF</title>
          <description>CRP of each participants was measured as a part of blood biochemical tests. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>milligram per deciliter (mg/dL)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.50" spread="1.633"/>
                    <measurement group_id="O2" value="1.44" spread="1.868"/>
                    <measurement group_id="O3" value="1.08" spread="0.840"/>
                    <measurement group_id="O4" value="1.24" spread="1.634"/>
                    <measurement group_id="O5" value="1.42" spread="1.682"/>
                    <measurement group_id="O6" value="1.41" spread="1.901"/>
                    <measurement group_id="O7" value="1.04" spread="0.843"/>
                    <measurement group_id="O8" value="1.07" spread="1.291"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="0.909"/>
                    <measurement group_id="O2" value="-0.28" spread="1.148"/>
                    <measurement group_id="O3" value="0.08" spread="0.707"/>
                    <measurement group_id="O4" value="0.07" spread="0.777"/>
                    <measurement group_id="O5" value="-0.16" spread="0.930"/>
                    <measurement group_id="O6" value="-0.32" spread="1.176"/>
                    <measurement group_id="O7" value="0.08" spread="0.715"/>
                    <measurement group_id="O8" value="0.12" spread="0.769"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="1.235"/>
                    <measurement group_id="O2" value="0.20" spread="1.279"/>
                    <measurement group_id="O3" value="0.04" spread="0.707"/>
                    <measurement group_id="O4" value="0.33" spread="1.383"/>
                    <measurement group_id="O5" value="-0.14" spread="1.134"/>
                    <measurement group_id="O6" value="0.15" spread="1.268"/>
                    <measurement group_id="O7" value="0.03" spread="0.694"/>
                    <measurement group_id="O8" value="0.28" spread="1.443"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="1.192"/>
                    <measurement group_id="O2" value="0.12" spread="1.750"/>
                    <measurement group_id="O3" value="0.29" spread="1.407"/>
                    <measurement group_id="O4" value="-0.03" spread="1.343"/>
                    <measurement group_id="O5" value="0.04" spread="1.103"/>
                    <measurement group_id="O6" value="0.08" spread="1.787"/>
                    <measurement group_id="O7" value="0.28" spread="1.452"/>
                    <measurement group_id="O8" value="-0.15" spread="1.392"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="1.503"/>
                    <measurement group_id="O2" value="-0.23" spread="1.429"/>
                    <measurement group_id="O3" value="-0.06" spread="1.263"/>
                    <measurement group_id="O4" value="-0.05" spread="1.403"/>
                    <measurement group_id="O5" value="0.01" spread="1.485"/>
                    <measurement group_id="O6" value="-0.26" spread="1.481"/>
                    <measurement group_id="O7" value="-0.07" spread="1.309"/>
                    <measurement group_id="O8" value="-0.24" spread="1.314"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.17" spread="1.429"/>
                    <measurement group_id="O2" value="-0.26" spread="1.626"/>
                    <measurement group_id="O3" value="-0.11" spread="1.214"/>
                    <measurement group_id="O4" value="0.09" spread="1.737"/>
                    <measurement group_id="O5" value="0.00" spread="1.412"/>
                    <measurement group_id="O6" value="-0.29" spread="1.684"/>
                    <measurement group_id="O7" value="-0.10" spread="1.249"/>
                    <measurement group_id="O8" value="-0.08" spread="1.713"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="1.686"/>
                    <measurement group_id="O2" value="-0.17" spread="1.683"/>
                    <measurement group_id="O3" value="-0.18" spread="1.071"/>
                    <measurement group_id="O4" value="0.01" spread="1.332"/>
                    <measurement group_id="O5" value="0.00" spread="1.652"/>
                    <measurement group_id="O6" value="-0.25" spread="1.712"/>
                    <measurement group_id="O7" value="-0.23" spread="1.060"/>
                    <measurement group_id="O8" value="-0.14" spread="1.154"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.39" spread="2.063"/>
                    <measurement group_id="O2" value="-0.26" spread="1.887"/>
                    <measurement group_id="O3" value="0.01" spread="1.155"/>
                    <measurement group_id="O4" value="0.38" spread="2.220"/>
                    <measurement group_id="O5" value="0.18" spread="2.106"/>
                    <measurement group_id="O6" value="-0.35" spread="1.924"/>
                    <measurement group_id="O7" value="-0.03" spread="1.161"/>
                    <measurement group_id="O8" value="0.30" spread="2.269"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.24" spread="1.792"/>
                    <measurement group_id="O6" value="-0.34" spread="1.603"/>
                    <measurement group_id="O7" value="-0.21" spread="0.997"/>
                    <measurement group_id="O8" value="-0.19" spread="1.677"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.10" spread="2.067"/>
                    <measurement group_id="O6" value="-0.32" spread="1.617"/>
                    <measurement group_id="O7" value="0.13" spread="1.585"/>
                    <measurement group_id="O8" value="-0.35" spread="1.371"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.10" spread="1.839"/>
                    <measurement group_id="O6" value="-0.13" spread="2.311"/>
                    <measurement group_id="O7" value="-0.04" spread="1.301"/>
                    <measurement group_id="O8" value="-0.24" spread="1.691"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.17" spread="1.852"/>
                    <measurement group_id="O6" value="-0.30" spread="1.801"/>
                    <measurement group_id="O7" value="-0.10" spread="1.100"/>
                    <measurement group_id="O8" value="-0.25" spread="1.539"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.10" spread="1.939"/>
                    <measurement group_id="O6" value="-0.35" spread="1.908"/>
                    <measurement group_id="O7" value="0.26" spread="1.798"/>
                    <measurement group_id="O8" value="-0.17" spread="1.470"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="0.14" spread="1.910"/>
                    <measurement group_id="O6" value="-0.25" spread="2.131"/>
                    <measurement group_id="O7" value="-0.04" spread="1.103"/>
                    <measurement group_id="O8" value="-0.32" spread="1.416"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="0.33" spread="2.130"/>
                    <measurement group_id="O6" value="-0.23" spread="2.288"/>
                    <measurement group_id="O7" value="-0.10" spread="1.134"/>
                    <measurement group_id="O8" value="-0.14" spread="1.162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.09" spread="1.967"/>
                    <measurement group_id="O6" value="-0.44" spread="2.001"/>
                    <measurement group_id="O7" value="-0.03" spread="1.264"/>
                    <measurement group_id="O8" value="-0.27" spread="1.124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.13" spread="1.956"/>
                    <measurement group_id="O6" value="-0.14" spread="2.375"/>
                    <measurement group_id="O7" value="-0.03" spread="1.266"/>
                    <measurement group_id="O8" value="-0.39" spread="1.276"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.04" spread="2.062"/>
                    <measurement group_id="O6" value="-0.34" spread="2.115"/>
                    <measurement group_id="O7" value="0.54" spread="4.066"/>
                    <measurement group_id="O8" value="-0.40" spread="1.307"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.26" spread="2.207"/>
                    <measurement group_id="O6" value="-0.23" spread="2.276"/>
                    <measurement group_id="O7" value="0.13" spread="1.662"/>
                    <measurement group_id="O8" value="-0.36" spread="1.414"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.17" spread="2.414"/>
                    <measurement group_id="O6" value="-0.27" spread="2.167"/>
                    <measurement group_id="O7" value="0.04" spread="1.550"/>
                    <measurement group_id="O8" value="-0.28" spread="1.437"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.09" spread="2.382"/>
                    <measurement group_id="O6" value="-0.38" spread="2.115"/>
                    <measurement group_id="O7" value="0.07" spread="1.593"/>
                    <measurement group_id="O8" value="-0.41" spread="1.329"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.20" spread="2.297"/>
                    <measurement group_id="O6" value="-0.32" spread="2.065"/>
                    <measurement group_id="O7" value="0.02" spread="1.524"/>
                    <measurement group_id="O8" value="-0.40" spread="1.260"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.23" spread="2.332"/>
                    <measurement group_id="O6" value="-0.39" spread="2.097"/>
                    <measurement group_id="O7" value="0.11" spread="1.754"/>
                    <measurement group_id="O8" value="-0.35" spread="1.417"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Erythrocyte Sedimentation Rate (ESR) Values at Each Visit Based on LOCF</title>
        <description>ESR were a type of blood test. An ESR was used to monitor the arthritis condition. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80,and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Erythrocyte Sedimentation Rate (ESR) Values at Each Visit Based on LOCF</title>
          <description>ESR were a type of blood test. An ESR was used to monitor the arthritis condition. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>millimeter per hour (mm/hr)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.6" spread="26.37"/>
                    <measurement group_id="O2" value="37.9" spread="16.62"/>
                    <measurement group_id="O3" value="40.8" spread="20.06"/>
                    <measurement group_id="O4" value="40.1" spread="20.45"/>
                    <measurement group_id="O5" value="39.6" spread="26.47"/>
                    <measurement group_id="O6" value="37.6" spread="17.21"/>
                    <measurement group_id="O7" value="40.0" spread="19.67"/>
                    <measurement group_id="O8" value="38.3" spread="16.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.8" spread="10.40"/>
                    <measurement group_id="O2" value="1.0" spread="8.25"/>
                    <measurement group_id="O3" value="-1.9" spread="7.53"/>
                    <measurement group_id="O4" value="0.7" spread="10.38"/>
                    <measurement group_id="O5" value="-4.1" spread="10.49"/>
                    <measurement group_id="O6" value="1.7" spread="8.00"/>
                    <measurement group_id="O7" value="-2.1" spread="7.70"/>
                    <measurement group_id="O8" value="0.4" spread="10.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.3" spread="14.51"/>
                    <measurement group_id="O2" value="1.3" spread="11.79"/>
                    <measurement group_id="O3" value="-2.6" spread="7.42"/>
                    <measurement group_id="O4" value="-1.1" spread="13.38"/>
                    <measurement group_id="O5" value="-3.4" spread="14.07"/>
                    <measurement group_id="O6" value="1.3" spread="12.22"/>
                    <measurement group_id="O7" value="-2.8" spread="7.62"/>
                    <measurement group_id="O8" value="-2.2" spread="13.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="17.72"/>
                    <measurement group_id="O2" value="-0.3" spread="11.62"/>
                    <measurement group_id="O3" value="-1.8" spread="14.43"/>
                    <measurement group_id="O4" value="-3.7" spread="15.09"/>
                    <measurement group_id="O5" value="-1.5" spread="16.90"/>
                    <measurement group_id="O6" value="-0.5" spread="11.55"/>
                    <measurement group_id="O7" value="-2.7" spread="14.19"/>
                    <measurement group_id="O8" value="-5.3" spread="15.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="16.46"/>
                    <measurement group_id="O2" value="-2.9" spread="15.53"/>
                    <measurement group_id="O3" value="-3.8" spread="18.39"/>
                    <measurement group_id="O4" value="-3.5" spread="17.83"/>
                    <measurement group_id="O5" value="-1.5" spread="15.28"/>
                    <measurement group_id="O6" value="-3.4" spread="16.00"/>
                    <measurement group_id="O7" value="-4.7" spread="18.38"/>
                    <measurement group_id="O8" value="-5.7" spread="17.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.9" spread="15.78"/>
                    <measurement group_id="O2" value="-3.3" spread="18.53"/>
                    <measurement group_id="O3" value="-5.5" spread="20.68"/>
                    <measurement group_id="O4" value="-2.2" spread="19.92"/>
                    <measurement group_id="O5" value="-3.6" spread="14.47"/>
                    <measurement group_id="O6" value="-3.8" spread="19.14"/>
                    <measurement group_id="O7" value="-6.0" spread="21.05"/>
                    <measurement group_id="O8" value="-4.7" spread="20.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="22.08"/>
                    <measurement group_id="O2" value="-1.3" spread="18.75"/>
                    <measurement group_id="O3" value="-6.6" spread="20.32"/>
                    <measurement group_id="O4" value="-4.0" spread="19.17"/>
                    <measurement group_id="O5" value="-2.3" spread="21.23"/>
                    <measurement group_id="O6" value="-2.3" spread="19.00"/>
                    <measurement group_id="O7" value="-8.0" spread="19.80"/>
                    <measurement group_id="O8" value="-6.8" spread="18.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="23.16"/>
                    <measurement group_id="O2" value="0.6" spread="20.14"/>
                    <measurement group_id="O3" value="-4.0" spread="21.67"/>
                    <measurement group_id="O4" value="-2.9" spread="20.41"/>
                    <measurement group_id="O5" value="-1.8" spread="22.56"/>
                    <measurement group_id="O6" value="-0.3" spread="20.57"/>
                    <measurement group_id="O7" value="-5.2" spread="21.47"/>
                    <measurement group_id="O8" value="-5.4" spread="20.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-4.6" spread="20.04"/>
                    <measurement group_id="O6" value="-4.3" spread="19.51"/>
                    <measurement group_id="O7" value="-3.4" spread="23.67"/>
                    <measurement group_id="O8" value="-8.0" spread="18.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-3.4" spread="21.50"/>
                    <measurement group_id="O6" value="-5.0" spread="16.34"/>
                    <measurement group_id="O7" value="-3.9" spread="23.50"/>
                    <measurement group_id="O8" value="-7.4" spread="20.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-4.7" spread="20.43"/>
                    <measurement group_id="O6" value="-4.5" spread="20.44"/>
                    <measurement group_id="O7" value="-1.9" spread="23.56"/>
                    <measurement group_id="O8" value="-4.8" spread="20.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-3.4" spread="19.46"/>
                    <measurement group_id="O6" value="-3.5" spread="19.77"/>
                    <measurement group_id="O7" value="-3.1" spread="24.00"/>
                    <measurement group_id="O8" value="-5.8" spread="21.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-3.2" spread="20.19"/>
                    <measurement group_id="O6" value="-4.4" spread="21.73"/>
                    <measurement group_id="O7" value="-3.2" spread="24.65"/>
                    <measurement group_id="O8" value="-4.8" spread="22.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-2.0" spread="19.12"/>
                    <measurement group_id="O6" value="-2.0" spread="20.91"/>
                    <measurement group_id="O7" value="-4.2" spread="20.41"/>
                    <measurement group_id="O8" value="-5.5" spread="19.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-0.6" spread="19.64"/>
                    <measurement group_id="O6" value="-1.8" spread="21.69"/>
                    <measurement group_id="O7" value="-2.5" spread="25.04"/>
                    <measurement group_id="O8" value="-4.9" spread="20.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-4.6" spread="21.59"/>
                    <measurement group_id="O6" value="-4.4" spread="20.37"/>
                    <measurement group_id="O7" value="-3.9" spread="23.46"/>
                    <measurement group_id="O8" value="-6.2" spread="19.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-4.9" spread="22.00"/>
                    <measurement group_id="O6" value="-2.6" spread="23.13"/>
                    <measurement group_id="O7" value="-3.6" spread="26.27"/>
                    <measurement group_id="O8" value="-7.6" spread="19.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-4.1" spread="24.32"/>
                    <measurement group_id="O6" value="-3.2" spread="22.29"/>
                    <measurement group_id="O7" value="-5.5" spread="24.06"/>
                    <measurement group_id="O8" value="-8.0" spread="18.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-4.0" spread="24.77"/>
                    <measurement group_id="O6" value="-3.2" spread="22.21"/>
                    <measurement group_id="O7" value="-5.9" spread="22.68"/>
                    <measurement group_id="O8" value="-8.7" spread="17.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-4.5" spread="27.08"/>
                    <measurement group_id="O6" value="-3.7" spread="20.94"/>
                    <measurement group_id="O7" value="-4.3" spread="24.37"/>
                    <measurement group_id="O8" value="-7.8" spread="20.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-4.2" spread="26.28"/>
                    <measurement group_id="O6" value="-4.8" spread="18.96"/>
                    <measurement group_id="O7" value="-4.4" spread="22.94"/>
                    <measurement group_id="O8" value="-7.9" spread="18.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-5.7" spread="27.22"/>
                    <measurement group_id="O6" value="-4.6" spread="19.36"/>
                    <measurement group_id="O7" value="-6.1" spread="24.45"/>
                    <measurement group_id="O8" value="-9.1" spread="18.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-5.9" spread="25.74"/>
                    <measurement group_id="O6" value="-5.1" spread="19.08"/>
                    <measurement group_id="O7" value="-3.0" spread="24.74"/>
                    <measurement group_id="O8" value="-8.1" spread="18.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Disease Activity Score 28 (DAS28)-ESR Values at Each Visit Based on LOCF</title>
        <description>The DAS28 index was a composite score of weighted components including tender joint counts of 28, swollen joint counts of 28, participant global assessment of disease activity score, and ESR value. Total score ranged between 0-10. A DAS28-ESR score of 5.1 or above = high disease activity, a value between 3.2 and 5.1 = moderate disease activity and value between 2.6 and 3.2 = low disease activity, value &lt;2.6 = disease remission. A positive change in score indicates worsening, and a negative change indicates improvement. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Disease Activity Score 28 (DAS28)-ESR Values at Each Visit Based on LOCF</title>
          <description>The DAS28 index was a composite score of weighted components including tender joint counts of 28, swollen joint counts of 28, participant global assessment of disease activity score, and ESR value. Total score ranged between 0-10. A DAS28-ESR score of 5.1 or above = high disease activity, a value between 3.2 and 5.1 = moderate disease activity and value between 2.6 and 3.2 = low disease activity, value &lt;2.6 = disease remission. A positive change in score indicates worsening, and a negative change indicates improvement. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.709" spread="0.9161"/>
                    <measurement group_id="O2" value="5.687" spread="0.9278"/>
                    <measurement group_id="O3" value="5.819" spread="0.7696"/>
                    <measurement group_id="O4" value="5.984" spread="0.8865"/>
                    <measurement group_id="O5" value="5.653" spread="0.9149"/>
                    <measurement group_id="O6" value="5.674" spread="0.9625"/>
                    <measurement group_id="O7" value="5.775" spread="0.6980"/>
                    <measurement group_id="O8" value="5.931" spread="0.8490"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.520" spread="0.7531"/>
                    <measurement group_id="O2" value="-0.402" spread="0.5058"/>
                    <measurement group_id="O3" value="-0.554" spread="0.6165"/>
                    <measurement group_id="O4" value="-0.420" spread="0.6906"/>
                    <measurement group_id="O5" value="-0.580" spread="0.7398"/>
                    <measurement group_id="O6" value="-0.392" spread="0.4917"/>
                    <measurement group_id="O7" value="-0.541" spread="0.6199"/>
                    <measurement group_id="O8" value="-0.436" spread="0.7121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.571" spread="0.8416"/>
                    <measurement group_id="O2" value="-0.434" spread="0.6825"/>
                    <measurement group_id="O3" value="-0.702" spread="0.6534"/>
                    <measurement group_id="O4" value="-0.833" spread="1.0092"/>
                    <measurement group_id="O5" value="-0.641" spread="0.8217"/>
                    <measurement group_id="O6" value="-0.423" spread="0.6709"/>
                    <measurement group_id="O7" value="-0.710" spread="0.6435"/>
                    <measurement group_id="O8" value="-0.896" spread="1.0426"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.674" spread="1.1682"/>
                    <measurement group_id="O2" value="-0.642" spread="0.8081"/>
                    <measurement group_id="O3" value="-0.919" spread="0.8813"/>
                    <measurement group_id="O4" value="-1.217" spread="1.1963"/>
                    <measurement group_id="O5" value="-0.839" spread="1.0703"/>
                    <measurement group_id="O6" value="-0.653" spread="0.7871"/>
                    <measurement group_id="O7" value="-0.947" spread="0.8681"/>
                    <measurement group_id="O8" value="-1.306" spread="1.2425"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.763" spread="1.2561"/>
                    <measurement group_id="O2" value="-1.007" spread="1.0644"/>
                    <measurement group_id="O3" value="-1.237" spread="1.0536"/>
                    <measurement group_id="O4" value="-1.277" spread="1.4323"/>
                    <measurement group_id="O5" value="-0.934" spread="1.1527"/>
                    <measurement group_id="O6" value="-1.053" spread="1.0693"/>
                    <measurement group_id="O7" value="-1.302" spread="0.9895"/>
                    <measurement group_id="O8" value="-1.443" spread="1.4777"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.022" spread="1.3026"/>
                    <measurement group_id="O2" value="-1.134" spread="1.1573"/>
                    <measurement group_id="O3" value="-1.391" spread="1.0674"/>
                    <measurement group_id="O4" value="-1.349" spread="1.4847"/>
                    <measurement group_id="O5" value="-1.242" spread="1.1588"/>
                    <measurement group_id="O6" value="-1.195" spread="1.1625"/>
                    <measurement group_id="O7" value="-1.445" spread="1.0294"/>
                    <measurement group_id="O8" value="-1.581" spread="1.4581"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.977" spread="1.3914"/>
                    <measurement group_id="O2" value="-1.156" spread="1.0949"/>
                    <measurement group_id="O3" value="-1.449" spread="1.2393"/>
                    <measurement group_id="O4" value="-1.525" spread="1.4998"/>
                    <measurement group_id="O5" value="-1.215" spread="1.2400"/>
                    <measurement group_id="O6" value="-1.226" spread="1.0921"/>
                    <measurement group_id="O7" value="-1.524" spread="1.1984"/>
                    <measurement group_id="O8" value="-1.787" spread="1.4405"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.950" spread="1.4587"/>
                    <measurement group_id="O2" value="-1.144" spread="1.2704"/>
                    <measurement group_id="O3" value="-1.470" spread="1.1853"/>
                    <measurement group_id="O4" value="-1.536" spread="1.5340"/>
                    <measurement group_id="O5" value="-1.185" spread="1.3317"/>
                    <measurement group_id="O6" value="-1.214" spread="1.2817"/>
                    <measurement group_id="O7" value="-1.546" spread="1.1363"/>
                    <measurement group_id="O8" value="-1.815" spread="1.4668"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.452" spread="1.3306"/>
                    <measurement group_id="O6" value="-1.397" spread="1.3890"/>
                    <measurement group_id="O7" value="-1.652" spread="1.2452"/>
                    <measurement group_id="O8" value="-1.913" spread="1.4510"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.512" spread="1.3217"/>
                    <measurement group_id="O6" value="-1.457" spread="1.2777"/>
                    <measurement group_id="O7" value="-1.617" spread="1.4220"/>
                    <measurement group_id="O8" value="-1.856" spread="1.5063"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.443" spread="1.3900"/>
                    <measurement group_id="O6" value="-1.336" spread="1.3160"/>
                    <measurement group_id="O7" value="-1.718" spread="1.2962"/>
                    <measurement group_id="O8" value="-1.994" spread="1.5330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.409" spread="1.3896"/>
                    <measurement group_id="O6" value="-1.362" spread="1.3332"/>
                    <measurement group_id="O7" value="-1.672" spread="1.1859"/>
                    <measurement group_id="O8" value="-1.947" spread="1.5247"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.367" spread="1.3085"/>
                    <measurement group_id="O6" value="-1.391" spread="1.2689"/>
                    <measurement group_id="O7" value="-1.727" spread="1.2501"/>
                    <measurement group_id="O8" value="-2.063" spread="1.5432"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.438" spread="1.4786"/>
                    <measurement group_id="O6" value="-1.447" spread="1.3270"/>
                    <measurement group_id="O7" value="-1.734" spread="1.2812"/>
                    <measurement group_id="O8" value="-2.004" spread="1.4325"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.387" spread="1.4577"/>
                    <measurement group_id="O6" value="-1.364" spread="1.2433"/>
                    <measurement group_id="O7" value="-1.682" spread="1.1280"/>
                    <measurement group_id="O8" value="-1.956" spread="1.4547"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.516" spread="1.4242"/>
                    <measurement group_id="O6" value="-1.398" spread="1.2493"/>
                    <measurement group_id="O7" value="-1.678" spread="1.2286"/>
                    <measurement group_id="O8" value="-2.122" spread="1.4580"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.528" spread="1.4876"/>
                    <measurement group_id="O6" value="-1.579" spread="1.3403"/>
                    <measurement group_id="O7" value="-1.764" spread="1.4278"/>
                    <measurement group_id="O8" value="-2.145" spread="1.4990"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.483" spread="1.4218"/>
                    <measurement group_id="O6" value="-1.538" spread="1.2862"/>
                    <measurement group_id="O7" value="-1.652" spread="1.3363"/>
                    <measurement group_id="O8" value="-2.188" spread="1.4525"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.598" spread="1.4828"/>
                    <measurement group_id="O6" value="-1.411" spread="1.3355"/>
                    <measurement group_id="O7" value="-1.729" spread="1.4047"/>
                    <measurement group_id="O8" value="-2.221" spread="1.4155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.528" spread="1.5740"/>
                    <measurement group_id="O6" value="-1.402" spread="1.2321"/>
                    <measurement group_id="O7" value="-1.742" spread="1.3978"/>
                    <measurement group_id="O8" value="-2.100" spread="1.4930"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.547" spread="1.6002"/>
                    <measurement group_id="O6" value="-1.458" spread="1.1877"/>
                    <measurement group_id="O7" value="-1.833" spread="1.3346"/>
                    <measurement group_id="O8" value="-2.133" spread="1.3671"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.580" spread="1.6735"/>
                    <measurement group_id="O6" value="-1.544" spread="1.2228"/>
                    <measurement group_id="O7" value="-1.773" spread="1.2908"/>
                    <measurement group_id="O8" value="-2.194" spread="1.4738"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.599" spread="1.5656"/>
                    <measurement group_id="O6" value="-1.584" spread="1.3414"/>
                    <measurement group_id="O7" value="-1.812" spread="1.3174"/>
                    <measurement group_id="O8" value="-2.206" spread="1.5263"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in DAS28-CRP Values at Each Visit Based on LOCF</title>
        <description>The DAS28 index was a composite score of weighted components including tender joint counts of 28, swollen joint counts of 28, participant global assessment of disease activity score, and CRP value. Total score ranged between 0-10. A DAS28-CRP score of 5.1 or above = high disease activity, a value between 3.2 and 5.1 = moderate disease activity and value between 2.6 and 3.2 = low disease activity, value &lt;2.6 = disease remission. A positive change in score indicates worsening, and a negative change indicates improvement. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in DAS28-CRP Values at Each Visit Based on LOCF</title>
          <description>The DAS28 index was a composite score of weighted components including tender joint counts of 28, swollen joint counts of 28, participant global assessment of disease activity score, and CRP value. Total score ranged between 0-10. A DAS28-CRP score of 5.1 or above = high disease activity, a value between 3.2 and 5.1 = moderate disease activity and value between 2.6 and 3.2 = low disease activity, value &lt;2.6 = disease remission. A positive change in score indicates worsening, and a negative change indicates improvement. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.039" spread="0.8789"/>
                    <measurement group_id="O2" value="4.993" spread="1.0096"/>
                    <measurement group_id="O3" value="5.079" spread="0.7290"/>
                    <measurement group_id="O4" value="5.202" spread="0.9283"/>
                    <measurement group_id="O5" value="4.997" spread="0.8561"/>
                    <measurement group_id="O6" value="4.978" spread="1.0458"/>
                    <measurement group_id="O7" value="5.034" spread="0.6676"/>
                    <measurement group_id="O8" value="5.138" spread="0.8998"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.474" spread="0.7500"/>
                    <measurement group_id="O2" value="-0.464" spread="0.5214"/>
                    <measurement group_id="O3" value="-0.531" spread="0.6404"/>
                    <measurement group_id="O4" value="-0.430" spread="0.7393"/>
                    <measurement group_id="O5" value="-0.534" spread="0.7370"/>
                    <measurement group_id="O6" value="-0.459" spread="0.5043"/>
                    <measurement group_id="O7" value="-0.514" spread="0.6403"/>
                    <measurement group_id="O8" value="-0.433" spread="0.7731"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.514" spread="0.8858"/>
                    <measurement group_id="O2" value="-0.407" spread="0.6521"/>
                    <measurement group_id="O3" value="-0.675" spread="0.6705"/>
                    <measurement group_id="O4" value="-0.704" spread="0.9959"/>
                    <measurement group_id="O5" value="-0.591" spread="0.8735"/>
                    <measurement group_id="O6" value="-0.391" spread="0.6202"/>
                    <measurement group_id="O7" value="-0.678" spread="0.6539"/>
                    <measurement group_id="O8" value="-0.747" spread="1.0501"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.607" spread="1.0640"/>
                    <measurement group_id="O2" value="-0.679" spread="0.8212"/>
                    <measurement group_id="O3" value="-0.885" spread="0.8535"/>
                    <measurement group_id="O4" value="-1.059" spread="1.1604"/>
                    <measurement group_id="O5" value="-0.767" spread="0.9529"/>
                    <measurement group_id="O6" value="-0.684" spread="0.7985"/>
                    <measurement group_id="O7" value="-0.905" spread="0.8341"/>
                    <measurement group_id="O8" value="-1.136" spread="1.2236"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.692" spread="1.2057"/>
                    <measurement group_id="O2" value="-1.028" spread="1.0399"/>
                    <measurement group_id="O3" value="-1.206" spread="1.0564"/>
                    <measurement group_id="O4" value="-1.164" spread="1.3302"/>
                    <measurement group_id="O5" value="-0.855" spread="1.0981"/>
                    <measurement group_id="O6" value="-1.071" spread="1.0433"/>
                    <measurement group_id="O7" value="-1.260" spread="1.0062"/>
                    <measurement group_id="O8" value="-1.321" spread="1.3768"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.913" spread="1.2429"/>
                    <measurement group_id="O2" value="-1.160" spread="1.0453"/>
                    <measurement group_id="O3" value="-1.339" spread="1.0190"/>
                    <measurement group_id="O4" value="-1.250" spread="1.4208"/>
                    <measurement group_id="O5" value="-1.125" spread="1.1056"/>
                    <measurement group_id="O6" value="-1.222" spread="1.0420"/>
                    <measurement group_id="O7" value="-1.385" spread="0.9817"/>
                    <measurement group_id="O8" value="-1.473" spread="1.3859"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.889" spread="1.3450"/>
                    <measurement group_id="O2" value="-1.186" spread="1.0136"/>
                    <measurement group_id="O3" value="-1.397" spread="1.2380"/>
                    <measurement group_id="O4" value="-1.437" spread="1.4440"/>
                    <measurement group_id="O5" value="-1.133" spread="1.1959"/>
                    <measurement group_id="O6" value="-1.264" spread="1.0004"/>
                    <measurement group_id="O7" value="-1.461" spread="1.2066"/>
                    <measurement group_id="O8" value="-1.692" spread="1.3754"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.825" spread="1.3502"/>
                    <measurement group_id="O2" value="-1.212" spread="1.1955"/>
                    <measurement group_id="O3" value="-1.449" spread="1.1679"/>
                    <measurement group_id="O4" value="-1.400" spread="1.4462"/>
                    <measurement group_id="O5" value="-1.058" spread="1.2175"/>
                    <measurement group_id="O6" value="-1.292" spread="1.1959"/>
                    <measurement group_id="O7" value="-1.518" spread="1.1251"/>
                    <measurement group_id="O8" value="-1.666" spread="1.3715"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.363" spread="1.2248"/>
                    <measurement group_id="O6" value="-1.386" spread="1.2327"/>
                    <measurement group_id="O7" value="-1.645" spread="1.2490"/>
                    <measurement group_id="O8" value="-1.770" spread="1.3779"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.438" spread="1.2821"/>
                    <measurement group_id="O6" value="-1.461" spread="1.1617"/>
                    <measurement group_id="O7" value="-1.545" spread="1.4075"/>
                    <measurement group_id="O8" value="-1.724" spread="1.4062"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.319" spread="1.2935"/>
                    <measurement group_id="O6" value="-1.329" spread="1.2331"/>
                    <measurement group_id="O7" value="-1.729" spread="1.2139"/>
                    <measurement group_id="O8" value="-1.910" spread="1.4317"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.343" spread="1.3170"/>
                    <measurement group_id="O6" value="-1.359" spread="1.1999"/>
                    <measurement group_id="O7" value="-1.688" spread="1.0828"/>
                    <measurement group_id="O8" value="-1.835" spread="1.4415"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.286" spread="1.2637"/>
                    <measurement group_id="O6" value="-1.334" spread="1.1039"/>
                    <measurement group_id="O7" value="-1.702" spread="1.2073"/>
                    <measurement group_id="O8" value="-1.915" spread="1.5062"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.338" spread="1.4080"/>
                    <measurement group_id="O6" value="-1.475" spread="1.2492"/>
                    <measurement group_id="O7" value="-1.658" spread="1.1945"/>
                    <measurement group_id="O8" value="-1.904" spread="1.3723"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.293" spread="1.4043"/>
                    <measurement group_id="O6" value="-1.407" spread="1.1550"/>
                    <measurement group_id="O7" value="-1.660" spread="1.1057"/>
                    <measurement group_id="O8" value="-1.815" spread="1.2919"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.425" spread="1.3826"/>
                    <measurement group_id="O6" value="-1.438" spread="1.1264"/>
                    <measurement group_id="O7" value="-1.603" spread="1.2139"/>
                    <measurement group_id="O8" value="-1.999" spread="1.3047"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.392" spread="1.4082"/>
                    <measurement group_id="O6" value="-1.557" spread="1.1507"/>
                    <measurement group_id="O7" value="-1.697" spread="1.3250"/>
                    <measurement group_id="O8" value="-2.015" spread="1.3216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.380" spread="1.3475"/>
                    <measurement group_id="O6" value="-1.530" spread="1.1474"/>
                    <measurement group_id="O7" value="-1.579" spread="1.2837"/>
                    <measurement group_id="O8" value="-2.039" spread="1.2069"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.520" spread="1.4072"/>
                    <measurement group_id="O6" value="-1.414" spread="1.2456"/>
                    <measurement group_id="O7" value="-1.627" spread="1.3523"/>
                    <measurement group_id="O8" value="-2.092" spread="1.2697"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.434" spread="1.4852"/>
                    <measurement group_id="O6" value="-1.398" spread="1.1240"/>
                    <measurement group_id="O7" value="-1.698" spread="1.2813"/>
                    <measurement group_id="O8" value="-1.946" spread="1.3801"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.445" spread="1.5266"/>
                    <measurement group_id="O6" value="-1.489" spread="1.1022"/>
                    <measurement group_id="O7" value="-1.783" spread="1.2366"/>
                    <measurement group_id="O8" value="-2.029" spread="1.2583"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.438" spread="1.5290"/>
                    <measurement group_id="O6" value="-1.544" spread="1.1475"/>
                    <measurement group_id="O7" value="-1.688" spread="1.1779"/>
                    <measurement group_id="O8" value="-2.069" spread="1.3821"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-1.524" spread="1.5688"/>
                    <measurement group_id="O6" value="-1.596" spread="1.2642"/>
                    <measurement group_id="O7" value="-1.750" spread="1.2376"/>
                    <measurement group_id="O8" value="-2.090" spread="1.4318"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Simple Disease Activity Index (SDAI) Values at Each Visit Based on LOCF</title>
        <description>The SDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-86. SDAI score of 26 or above = high disease activity, a value between 11 and 26 = moderate disease activity and value less than or equal to (&lt;=) 11 = low disease activity, value &lt;=33 = disease remission. Higher scores indicated higher disease activity. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Simple Disease Activity Index (SDAI) Values at Each Visit Based on LOCF</title>
          <description>The SDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-86. SDAI score of 26 or above = high disease activity, a value between 11 and 26 = moderate disease activity and value less than or equal to (&lt;=) 11 = low disease activity, value &lt;=33 = disease remission. Higher scores indicated higher disease activity. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.694" spread="10.7598"/>
                    <measurement group_id="O2" value="30.546" spread="12.5152"/>
                    <measurement group_id="O3" value="31.646" spread="9.3821"/>
                    <measurement group_id="O4" value="34.413" spread="12.6292"/>
                    <measurement group_id="O5" value="30.317" spread="10.5425"/>
                    <measurement group_id="O6" value="30.604" spread="12.9983"/>
                    <measurement group_id="O7" value="30.962" spread="8.2366"/>
                    <measurement group_id="O8" value="33.915" spread="11.9378"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.093" spread="8.0941"/>
                    <measurement group_id="O2" value="-5.618" spread="6.0585"/>
                    <measurement group_id="O3" value="-6.704" spread="6.9970"/>
                    <measurement group_id="O4" value="-6.352" spread="9.5528"/>
                    <measurement group_id="O5" value="-5.800" spread="6.9371"/>
                    <measurement group_id="O6" value="-5.458" spread="6.1238"/>
                    <measurement group_id="O7" value="-6.434" spread="6.8409"/>
                    <measurement group_id="O8" value="-6.539" spread="9.9950"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.722" spread="8.8627"/>
                    <measurement group_id="O2" value="-4.889" spread="7.3568"/>
                    <measurement group_id="O3" value="-7.948" spread="7.1614"/>
                    <measurement group_id="O4" value="-9.819" spread="11.2688"/>
                    <measurement group_id="O5" value="-6.560" spread="8.0631"/>
                    <measurement group_id="O6" value="-4.754" spread="7.0439"/>
                    <measurement group_id="O7" value="-8.050" spread="6.9054"/>
                    <measurement group_id="O8" value="-10.433" spread="11.8548"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.241" spread="12.4374"/>
                    <measurement group_id="O2" value="-7.636" spread="9.0091"/>
                    <measurement group_id="O3" value="-9.531" spread="9.5254"/>
                    <measurement group_id="O4" value="-12.839" spread="13.1334"/>
                    <measurement group_id="O5" value="-9.323" spread="9.2809"/>
                    <measurement group_id="O6" value="-7.627" spread="8.9115"/>
                    <measurement group_id="O7" value="-9.668" spread="9.4114"/>
                    <measurement group_id="O8" value="-13.926" spread="13.7928"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.546" spread="13.0215"/>
                    <measurement group_id="O2" value="-10.132" spread="10.8337"/>
                    <measurement group_id="O3" value="-12.089" spread="10.0806"/>
                    <measurement group_id="O4" value="-13.383" spread="14.5075"/>
                    <measurement group_id="O5" value="-9.660" spread="9.8693"/>
                    <measurement group_id="O6" value="-10.438" spread="10.8236"/>
                    <measurement group_id="O7" value="-12.688" spread="9.5421"/>
                    <measurement group_id="O8" value="-14.861" spread="15.0025"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.294" spread="13.2176"/>
                    <measurement group_id="O2" value="-12.043" spread="10.7104"/>
                    <measurement group_id="O3" value="-13.809" spread="9.8357"/>
                    <measurement group_id="O4" value="-14.152" spread="14.9552"/>
                    <measurement group_id="O5" value="-11.853" spread="9.8578"/>
                    <measurement group_id="O6" value="-12.565" spread="10.6334"/>
                    <measurement group_id="O7" value="-14.322" spread="9.4641"/>
                    <measurement group_id="O8" value="-16.617" spread="14.1166"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.996" spread="14.7780"/>
                    <measurement group_id="O2" value="-12.446" spread="11.0107"/>
                    <measurement group_id="O3" value="-13.724" spread="11.8173"/>
                    <measurement group_id="O4" value="-15.011" spread="14.9433"/>
                    <measurement group_id="O5" value="-11.857" spread="11.8911"/>
                    <measurement group_id="O6" value="-13.112" spread="10.9374"/>
                    <measurement group_id="O7" value="-14.342" spread="11.5579"/>
                    <measurement group_id="O8" value="-17.626" spread="13.9147"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.691" spread="14.3072"/>
                    <measurement group_id="O2" value="-12.671" spread="11.6001"/>
                    <measurement group_id="O3" value="-14.743" spread="11.6082"/>
                    <measurement group_id="O4" value="-14.883" spread="14.9074"/>
                    <measurement group_id="O5" value="-11.506" spread="11.2985"/>
                    <measurement group_id="O6" value="-13.354" spread="11.5619"/>
                    <measurement group_id="O7" value="-15.442" spread="11.2609"/>
                    <measurement group_id="O8" value="-17.698" spread="13.7260"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-13.996" spread="12.0029"/>
                    <measurement group_id="O6" value="-14.858" spread="12.5133"/>
                    <measurement group_id="O7" value="-16.818" spread="11.9239"/>
                    <measurement group_id="O8" value="-18.889" spread="13.9459"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-15.079" spread="12.8557"/>
                    <measurement group_id="O6" value="-15.423" spread="12.0649"/>
                    <measurement group_id="O7" value="-15.476" spread="13.3711"/>
                    <measurement group_id="O8" value="-18.833" spread="14.4014"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.017" spread="13.8170"/>
                    <measurement group_id="O6" value="-14.150" spread="11.6401"/>
                    <measurement group_id="O7" value="-17.282" spread="11.4617"/>
                    <measurement group_id="O8" value="-20.687" spread="14.6462"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.391" spread="14.1550"/>
                    <measurement group_id="O6" value="-14.612" spread="11.3920"/>
                    <measurement group_id="O7" value="-17.076" spread="9.4960"/>
                    <measurement group_id="O8" value="-19.520" spread="14.2756"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-13.538" spread="13.2755"/>
                    <measurement group_id="O6" value="-14.404" spread="11.6971"/>
                    <measurement group_id="O7" value="-16.800" spread="10.1413"/>
                    <measurement group_id="O8" value="-20.109" spread="15.3423"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-13.832" spread="14.8785"/>
                    <measurement group_id="O6" value="-14.912" spread="12.1638"/>
                    <measurement group_id="O7" value="-16.926" spread="11.5097"/>
                    <measurement group_id="O8" value="-19.939" spread="14.1463"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-13.251" spread="14.2737"/>
                    <measurement group_id="O6" value="-14.265" spread="11.9806"/>
                    <measurement group_id="O7" value="-16.856" spread="9.6991"/>
                    <measurement group_id="O8" value="-19.215" spread="13.0405"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.113" spread="13.7397"/>
                    <measurement group_id="O6" value="-14.904" spread="11.8237"/>
                    <measurement group_id="O7" value="-16.258" spread="11.2435"/>
                    <measurement group_id="O8" value="-20.439" spread="13.0531"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.166" spread="13.8122"/>
                    <measurement group_id="O6" value="-15.538" spread="11.5883"/>
                    <measurement group_id="O7" value="-16.628" spread="12.4186"/>
                    <measurement group_id="O8" value="-20.746" spread="13.3296"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.732" spread="14.5591"/>
                    <measurement group_id="O6" value="-15.492" spread="11.6393"/>
                    <measurement group_id="O7" value="-15.386" spread="12.5672"/>
                    <measurement group_id="O8" value="-20.611" spread="12.3814"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-15.549" spread="14.3214"/>
                    <measurement group_id="O6" value="-14.185" spread="13.1359"/>
                    <measurement group_id="O7" value="-16.294" spread="12.4571"/>
                    <measurement group_id="O8" value="-21.280" spread="12.9457"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.706" spread="14.9924"/>
                    <measurement group_id="O6" value="-14.619" spread="12.0768"/>
                    <measurement group_id="O7" value="-16.788" spread="11.9283"/>
                    <measurement group_id="O8" value="-20.348" spread="12.9401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.621" spread="14.7575"/>
                    <measurement group_id="O6" value="-14.977" spread="11.4630"/>
                    <measurement group_id="O7" value="-17.514" spread="12.1319"/>
                    <measurement group_id="O8" value="-20.696" spread="12.4896"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.289" spread="15.0957"/>
                    <measurement group_id="O6" value="-15.888" spread="11.9316"/>
                    <measurement group_id="O7" value="-17.069" spread="11.6199"/>
                    <measurement group_id="O8" value="-20.822" spread="13.5723"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.906" spread="15.1056"/>
                    <measurement group_id="O6" value="-15.419" spread="11.9932"/>
                    <measurement group_id="O7" value="-17.233" spread="11.9661"/>
                    <measurement group_id="O8" value="-20.485" spread="14.2038"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Clinical Disease Activity Index (CDAI) Values at Each Visit Based on LOCF</title>
        <description>The CDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-76. CDAI score of 22 or above = high disease activity, a value between 10 and 22 = moderate disease activity and value less than or equal to &lt;=10 = low disease activity, value &lt;=2.8 = disease remission. Higher scores indicated higher disease activity. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Clinical Disease Activity Index (CDAI) Values at Each Visit Based on LOCF</title>
          <description>The CDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-76. CDAI score of 22 or above = high disease activity, a value between 10 and 22 = moderate disease activity and value less than or equal to &lt;=10 = low disease activity, value &lt;=2.8 = disease remission. Higher scores indicated higher disease activity. Data reported for the Extension Phase from Baseline to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using LOCF imputation.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.198" spread="10.1188"/>
                    <measurement group_id="O2" value="29.104" spread="11.3057"/>
                    <measurement group_id="O3" value="30.563" spread="9.3260"/>
                    <measurement group_id="O4" value="33.169" spread="12.0220"/>
                    <measurement group_id="O5" value="28.900" spread="9.9333"/>
                    <measurement group_id="O6" value="29.196" spread="11.7439"/>
                    <measurement group_id="O7" value="29.918" spread="8.2741"/>
                    <measurement group_id="O8" value="32.848" spread="11.4735"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.007" spread="7.9447"/>
                    <measurement group_id="O2" value="-5.336" spread="6.0158"/>
                    <measurement group_id="O3" value="-6.785" spread="6.8641"/>
                    <measurement group_id="O4" value="-6.424" spread="9.5389"/>
                    <measurement group_id="O5" value="-5.640" spread="6.8069"/>
                    <measurement group_id="O6" value="-5.142" spread="6.0961"/>
                    <measurement group_id="O7" value="-6.518" spread="6.7345"/>
                    <measurement group_id="O8" value="-6.663" spread="9.9570"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.787" spread="8.3763"/>
                    <measurement group_id="O2" value="-5.093" spread="6.9306"/>
                    <measurement group_id="O3" value="-7.983" spread="7.0449"/>
                    <measurement group_id="O4" value="-10.152" spread="10.7576"/>
                    <measurement group_id="O5" value="-6.421" spread="7.7106"/>
                    <measurement group_id="O6" value="-4.904" spread="6.6827"/>
                    <measurement group_id="O7" value="-8.080" spread="6.8543"/>
                    <measurement group_id="O8" value="-10.713" spread="11.3327"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.456" spread="11.9815"/>
                    <measurement group_id="O2" value="-7.754" spread="8.3585"/>
                    <measurement group_id="O3" value="-9.824" spread="9.4091"/>
                    <measurement group_id="O4" value="-12.809" spread="12.4854"/>
                    <measurement group_id="O5" value="-9.364" spread="9.0361"/>
                    <measurement group_id="O6" value="-7.704" spread="8.2942"/>
                    <measurement group_id="O7" value="-9.946" spread="9.3095"/>
                    <measurement group_id="O8" value="-13.778" spread="13.1305"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.700" spread="12.4359"/>
                    <measurement group_id="O2" value="-9.900" spread="10.7410"/>
                    <measurement group_id="O3" value="-12.391" spread="9.5546"/>
                    <measurement group_id="O4" value="-13.335" spread="13.7520"/>
                    <measurement group_id="O5" value="-9.666" spread="9.4769"/>
                    <measurement group_id="O6" value="-10.177" spread="10.7463"/>
                    <measurement group_id="O7" value="-13.012" spread="8.9533"/>
                    <measurement group_id="O8" value="-14.617" spread="14.3068"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.469" spread="12.5253"/>
                    <measurement group_id="O2" value="-11.786" spread="10.2476"/>
                    <measurement group_id="O3" value="-13.698" spread="9.5039"/>
                    <measurement group_id="O4" value="-14.243" spread="14.0490"/>
                    <measurement group_id="O5" value="-11.853" spread="9.2509"/>
                    <measurement group_id="O6" value="-12.273" spread="10.1616"/>
                    <measurement group_id="O7" value="-14.220" spread="9.1180"/>
                    <measurement group_id="O8" value="-16.541" spread="13.2391"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.231" spread="14.0979"/>
                    <measurement group_id="O2" value="-12.279" spread="10.3590"/>
                    <measurement group_id="O3" value="-13.548" spread="11.4067"/>
                    <measurement group_id="O4" value="-15.113" spread="14.3180"/>
                    <measurement group_id="O5" value="-11.857" spread="11.3698"/>
                    <measurement group_id="O6" value="-12.862" spread="10.2616"/>
                    <measurement group_id="O7" value="-14.108" spread="11.1938"/>
                    <measurement group_id="O8" value="-17.487" spread="13.3908"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.080" spread="13.2957"/>
                    <measurement group_id="O2" value="-12.411" spread="10.6684"/>
                    <measurement group_id="O3" value="-14.815" spread="11.3164"/>
                    <measurement group_id="O4" value="-15.361" spread="14.0888"/>
                    <measurement group_id="O5" value="-11.683" spread="10.2413"/>
                    <measurement group_id="O6" value="-13.004" spread="10.5902"/>
                    <measurement group_id="O7" value="-15.476" spread="11.0172"/>
                    <measurement group_id="O8" value="-18.000" spread="12.8580"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-13.753" spread="11.1661"/>
                    <measurement group_id="O6" value="-14.519" spread="11.5712"/>
                    <measurement group_id="O7" value="-16.604" spread="11.5179"/>
                    <measurement group_id="O8" value="-18.700" spread="13.2130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.981" spread="11.8964"/>
                    <measurement group_id="O6" value="-15.108" spread="11.2046"/>
                    <measurement group_id="O7" value="-15.606" spread="12.5181"/>
                    <measurement group_id="O8" value="-18.478" spread="13.6585"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-13.917" spread="13.0248"/>
                    <measurement group_id="O6" value="-14.015" spread="10.4490"/>
                    <measurement group_id="O7" value="-17.134" spread="10.9034"/>
                    <measurement group_id="O8" value="-20.450" spread="13.8226"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.226" spread="13.3556"/>
                    <measurement group_id="O6" value="-14.315" spread="10.3937"/>
                    <measurement group_id="O7" value="-16.980" spread="9.3329"/>
                    <measurement group_id="O8" value="-19.274" spread="13.4909"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-13.440" spread="12.6798"/>
                    <measurement group_id="O6" value="-14.058" spread="10.6267"/>
                    <measurement group_id="O7" value="-17.060" spread="9.8900"/>
                    <measurement group_id="O8" value="-19.941" spread="14.6274"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-13.977" spread="14.2191"/>
                    <measurement group_id="O6" value="-14.658" spread="11.0874"/>
                    <measurement group_id="O7" value="-16.884" spread="11.0023"/>
                    <measurement group_id="O8" value="-19.624" spread="13.4005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-13.577" spread="13.4474"/>
                    <measurement group_id="O6" value="-14.031" spread="10.7633"/>
                    <measurement group_id="O7" value="-16.764" spread="9.4282"/>
                    <measurement group_id="O8" value="-19.076" spread="12.7465"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.019" spread="12.9269"/>
                    <measurement group_id="O6" value="-14.462" spread="10.8608"/>
                    <measurement group_id="O7" value="-16.228" spread="10.8175"/>
                    <measurement group_id="O8" value="-20.167" spread="12.7089"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.032" spread="12.9707"/>
                    <measurement group_id="O6" value="-15.400" spread="10.4881"/>
                    <measurement group_id="O7" value="-16.592" spread="11.8366"/>
                    <measurement group_id="O8" value="-20.354" spread="12.8739"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.687" spread="13.6997"/>
                    <measurement group_id="O6" value="-15.150" spread="10.5316"/>
                    <measurement group_id="O7" value="-15.924" spread="11.5956"/>
                    <measurement group_id="O8" value="-20.215" spread="12.0216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-15.291" spread="13.2786"/>
                    <measurement group_id="O6" value="-13.958" spread="12.0080"/>
                    <measurement group_id="O7" value="-16.422" spread="11.7994"/>
                    <measurement group_id="O8" value="-20.917" spread="12.3462"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.536" spread="13.7461"/>
                    <measurement group_id="O6" value="-14.346" spread="10.9159"/>
                    <measurement group_id="O7" value="-16.828" spread="11.2797"/>
                    <measurement group_id="O8" value="-20.063" spread="12.2151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.536" spread="13.4853"/>
                    <measurement group_id="O6" value="-14.600" spread="10.4240"/>
                    <measurement group_id="O7" value="-17.556" spread="11.5861"/>
                    <measurement group_id="O8" value="-20.289" spread="11.8557"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.091" spread="14.0501"/>
                    <measurement group_id="O6" value="-15.565" spread="10.7890"/>
                    <measurement group_id="O7" value="-17.090" spread="11.0248"/>
                    <measurement group_id="O8" value="-20.420" spread="12.9597"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="-14.679" spread="13.9556"/>
                    <measurement group_id="O6" value="-15.031" spread="10.8769"/>
                    <measurement group_id="O7" value="-17.344" spread="11.2309"/>
                    <measurement group_id="O8" value="-20.139" spread="13.4967"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With a European League Against Rheumatism (EULAR) Good, Moderate or No Response Using DAS28-ESR at Each Visit Based on NRI</title>
        <description>The Disease Activity Score Based on 28-joints Count based EULAR response criteria were used to measure individual response as none, good, and moderate, depending on the extent of change from baseline and the level of disease activity reached. Good responders: change from baseline &gt;1.2 with DAS28 &lt;=3.2; moderate responders: change from baseline &gt;1.2 with DAS28 &gt;3.2 to &lt;=5.1 or change from baseline &gt;0.6 to &lt;=1.2 with DAS28 &lt;=5.1; non-responders: change from baseline &lt;=0.6 or change from baseline &gt;0.6 and &lt;=1.2 with DAS28 &gt;5.1. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using NRI imputation.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a European League Against Rheumatism (EULAR) Good, Moderate or No Response Using DAS28-ESR at Each Visit Based on NRI</title>
          <description>The Disease Activity Score Based on 28-joints Count based EULAR response criteria were used to measure individual response as none, good, and moderate, depending on the extent of change from baseline and the level of disease activity reached. Good responders: change from baseline &gt;1.2 with DAS28 &lt;=3.2; moderate responders: change from baseline &gt;1.2 with DAS28 &gt;3.2 to &lt;=5.1 or change from baseline &gt;0.6 to &lt;=1.2 with DAS28 &lt;=5.1; non-responders: change from baseline &lt;=0.6 or change from baseline &gt;0.6 and &lt;=1.2 with DAS28 &gt;5.1. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using NRI imputation.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>EULAR response at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="53"/>
                    <count group_id="O5" value="46"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="39"/>
                    <measurement group_id="O4" value="42"/>
                    <measurement group_id="O5" value="32"/>
                    <measurement group_id="O6" value="17"/>
                    <measurement group_id="O7" value="35"/>
                    <measurement group_id="O8" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="21"/>
                    <measurement group_id="O8" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="31"/>
                    <measurement group_id="O4" value="32"/>
                    <measurement group_id="O5" value="31"/>
                    <measurement group_id="O6" value="18"/>
                    <measurement group_id="O7" value="28"/>
                    <measurement group_id="O8" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="28"/>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="26"/>
                    <measurement group_id="O8" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="25"/>
                    <measurement group_id="O6" value="13"/>
                    <measurement group_id="O7" value="21"/>
                    <measurement group_id="O8" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="26"/>
                    <measurement group_id="O8" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="24"/>
                    <measurement group_id="O5" value="24"/>
                    <measurement group_id="O6" value="13"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="29"/>
                    <measurement group_id="O4" value="24"/>
                    <measurement group_id="O5" value="21"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="29"/>
                    <measurement group_id="O8" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="21"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="20"/>
                    <measurement group_id="O6" value="14"/>
                    <measurement group_id="O7" value="23"/>
                    <measurement group_id="O8" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="21"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="27"/>
                    <measurement group_id="O4" value="21"/>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="27"/>
                    <measurement group_id="O8" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="21"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="22"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="29"/>
                    <measurement group_id="O8" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="13"/>
                    <measurement group_id="O7" value="26"/>
                    <measurement group_id="O8" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="25"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="29"/>
                    <measurement group_id="O8" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="24"/>
                    <measurement group_id="O8" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="24"/>
                    <measurement group_id="O8" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="23"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="23"/>
                    <measurement group_id="O8" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="22"/>
                    <measurement group_id="O8" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="27"/>
                    <measurement group_id="O8" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="21"/>
                    <measurement group_id="O8" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="19"/>
                    <measurement group_id="O8" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="19"/>
                    <measurement group_id="O8" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="18"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="18"/>
                    <measurement group_id="O8" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="21"/>
                    <measurement group_id="O8" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="21"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="21"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With a EULAR Good or Moderate Response Using DAS28-CRP at Each Visit Based on NRI</title>
        <description>The Disease Activity Score Based on 28-joints Count based EULAR response criteria were used to measure individual response as none, good, and moderate, depending on the extent of change from baseline and the level of disease activity reached. Good responders: change from baseline &gt;1.2 with DAS28 &lt;=3.2; moderate responders: change from baseline &gt;1.2 with DAS28 &gt;3.2 to &lt;=5.1 or change from baseline &gt;0.6 to &lt;=1.2 with DAS28 &lt;=5.1; non-responders: change from baseline &lt;=0.6 or change from baseline &gt;0.6 and &lt;=1.2 with DAS28 &gt;5.1. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using NRI.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a EULAR Good or Moderate Response Using DAS28-CRP at Each Visit Based on NRI</title>
          <description>The Disease Activity Score Based on 28-joints Count based EULAR response criteria were used to measure individual response as none, good, and moderate, depending on the extent of change from baseline and the level of disease activity reached. Good responders: change from baseline &gt;1.2 with DAS28 &lt;=3.2; moderate responders: change from baseline &gt;1.2 with DAS28 &gt;3.2 to &lt;=5.1 or change from baseline &gt;0.6 to &lt;=1.2 with DAS28 &lt;=5.1; non-responders: change from baseline &lt;=0.6 or change from baseline &gt;0.6 and &lt;=1.2 with DAS28 &gt;5.1. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using NRI.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>EULAR response at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="39"/>
                    <measurement group_id="O4" value="42"/>
                    <measurement group_id="O5" value="34"/>
                    <measurement group_id="O6" value="20"/>
                    <measurement group_id="O7" value="38"/>
                    <measurement group_id="O8" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="34"/>
                    <measurement group_id="O4" value="33"/>
                    <measurement group_id="O5" value="33"/>
                    <measurement group_id="O6" value="19"/>
                    <measurement group_id="O7" value="31"/>
                    <measurement group_id="O8" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="19"/>
                    <measurement group_id="O8" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="27"/>
                    <measurement group_id="O4" value="25"/>
                    <measurement group_id="O5" value="29"/>
                    <measurement group_id="O6" value="14"/>
                    <measurement group_id="O7" value="24"/>
                    <measurement group_id="O8" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="21"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="25"/>
                    <measurement group_id="O5" value="25"/>
                    <measurement group_id="O6" value="13"/>
                    <measurement group_id="O7" value="20"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="23"/>
                    <measurement group_id="O8" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="24"/>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="21"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="22"/>
                    <measurement group_id="O5" value="22"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="18"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="22"/>
                    <measurement group_id="O6" value="13"/>
                    <measurement group_id="O7" value="18"/>
                    <measurement group_id="O8" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="23"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="21"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="14"/>
                    <measurement group_id="O7" value="19"/>
                    <measurement group_id="O8" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="23"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="22"/>
                    <measurement group_id="O8" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="22"/>
                    <measurement group_id="O8" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="20"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="20"/>
                    <measurement group_id="O8" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="21"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="18"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="21"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="20"/>
                    <measurement group_id="O6" value="13"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="13"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="19"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="18"/>
                    <measurement group_id="O8" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="18"/>
                    <measurement group_id="O8" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="12"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="19"/>
                    <measurement group_id="O8" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="19"/>
                    <measurement group_id="O8" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="18"/>
                    <measurement group_id="O8" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="14"/>
                    <measurement group_id="O8" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="19"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>EULAR response at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Good response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="19"/>
                    <measurement group_id="O8" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="15"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No response</title>
                  <measurement_list>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Who Achieved SDAI Remission at Each Visit Based on NRI</title>
        <description>The SDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-86. SDAI score of 26 or above = high disease activity, a value between 11 and 26 = moderate disease activity and value &lt;=11 = low disease activity. Higher scores indicated higher disease activity. SDAI Remission was defined as SDAI score &lt;=3.3. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Baseline, Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, 84, 88, 92, 96, 100, and 104</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using NRI.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Who Achieved SDAI Remission at Each Visit Based on NRI</title>
          <description>The SDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-86. SDAI score of 26 or above = high disease activity, a value between 11 and 26 = moderate disease activity and value &lt;=11 = low disease activity. Higher scores indicated higher disease activity. SDAI Remission was defined as SDAI score &lt;=3.3. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using NRI.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Remission at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O5" value="2.1" lower_limit="0.00" upper_limit="6.25"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O7" value="2.0" lower_limit="0.00" upper_limit="5.88"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O2" value="3.6" lower_limit="0.00" upper_limit="10.45"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O6" value="3.8" lower_limit="0.00" upper_limit="11.24"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O2" value="10.7" lower_limit="0.00" upper_limit="22.17"/>
                    <measurement group_id="O3" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O4" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O5" value="2.1" lower_limit="0.00" upper_limit="6.25"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="4.0" lower_limit="0.00" upper_limit="9.43"/>
                    <measurement group_id="O8" value="2.2" lower_limit="0.00" upper_limit="6.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O2" value="10.7" lower_limit="0.00" upper_limit="22.17"/>
                    <measurement group_id="O3" value="5.6" lower_limit="0.00" upper_limit="11.67"/>
                    <measurement group_id="O4" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O5" value="4.3" lower_limit="0.00" upper_limit="10.03"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="4.3" lower_limit="0.00" upper_limit="10.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" lower_limit="0.42" upper_limit="14.39"/>
                    <measurement group_id="O2" value="14.3" lower_limit="1.32" upper_limit="27.25"/>
                    <measurement group_id="O3" value="7.4" lower_limit="0.42" upper_limit="14.39"/>
                    <measurement group_id="O4" value="9.3" lower_limit="1.53" upper_limit="16.99"/>
                    <measurement group_id="O5" value="8.5" lower_limit="0.53" upper_limit="16.49"/>
                    <measurement group_id="O6" value="15.4" lower_limit="1.52" upper_limit="29.25"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="10.9" lower_limit="1.87" upper_limit="19.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" lower_limit="0.00" upper_limit="11.67"/>
                    <measurement group_id="O2" value="7.1" lower_limit="0.00" upper_limit="16.68"/>
                    <measurement group_id="O3" value="7.4" lower_limit="0.42" upper_limit="14.39"/>
                    <measurement group_id="O4" value="11.1" lower_limit="2.73" upper_limit="19.49"/>
                    <measurement group_id="O5" value="6.4" lower_limit="0.00" upper_limit="13.37"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="13.0" lower_limit="3.31" upper_limit="22.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="6.4" lower_limit="0.00" upper_limit="13.37"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="10.0" lower_limit="1.68" upper_limit="18.32"/>
                    <measurement group_id="O8" value="10.9" lower_limit="1.87" upper_limit="19.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="8.5" lower_limit="0.53" upper_limit="16.49"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="10.0" lower_limit="1.68" upper_limit="18.32"/>
                    <measurement group_id="O8" value="13.0" lower_limit="3.31" upper_limit="22.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="8.5" lower_limit="0.53" upper_limit="16.49"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="14.0" lower_limit="4.38" upper_limit="23.62"/>
                    <measurement group_id="O8" value="13.0" lower_limit="3.31" upper_limit="22.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="12.8" lower_limit="3.23" upper_limit="22.31"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="12.0" lower_limit="2.99" upper_limit="21.01"/>
                    <measurement group_id="O8" value="15.2" lower_limit="4.84" upper_limit="25.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="10.6" lower_limit="1.82" upper_limit="19.45"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="16.0" lower_limit="5.84" upper_limit="26.16"/>
                    <measurement group_id="O8" value="15.2" lower_limit="4.84" upper_limit="25.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="17.0" lower_limit="6.28" upper_limit="27.77"/>
                    <measurement group_id="O6" value="19.2" lower_limit="4.08" upper_limit="34.38"/>
                    <measurement group_id="O7" value="12.0" lower_limit="2.99" upper_limit="21.01"/>
                    <measurement group_id="O8" value="21.7" lower_limit="9.82" upper_limit="33.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="17.0" lower_limit="6.28" upper_limit="27.77"/>
                    <measurement group_id="O6" value="15.4" lower_limit="1.52" upper_limit="29.25"/>
                    <measurement group_id="O7" value="10.0" lower_limit="1.68" upper_limit="18.32"/>
                    <measurement group_id="O8" value="13.0" lower_limit="3.31" upper_limit="22.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="14.9" lower_limit="4.72" upper_limit="25.07"/>
                    <measurement group_id="O6" value="15.4" lower_limit="1.52" upper_limit="29.25"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="17.4" lower_limit="6.44" upper_limit="28.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="12.8" lower_limit="3.23" upper_limit="22.31"/>
                    <measurement group_id="O6" value="19.2" lower_limit="4.08" upper_limit="34.38"/>
                    <measurement group_id="O7" value="16.0" lower_limit="5.84" upper_limit="26.16"/>
                    <measurement group_id="O8" value="13.0" lower_limit="3.31" upper_limit="22.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="10.6" lower_limit="1.82" upper_limit="19.45"/>
                    <measurement group_id="O6" value="19.2" lower_limit="4.08" upper_limit="34.38"/>
                    <measurement group_id="O7" value="12.0" lower_limit="2.99" upper_limit="21.01"/>
                    <measurement group_id="O8" value="10.9" lower_limit="1.87" upper_limit="19.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="19.1" lower_limit="7.90" upper_limit="30.40"/>
                    <measurement group_id="O6" value="23.1" lower_limit="6.88" upper_limit="39.27"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="17.4" lower_limit="6.44" upper_limit="28.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="10.6" lower_limit="1.82" upper_limit="19.45"/>
                    <measurement group_id="O6" value="19.2" lower_limit="4.08" upper_limit="34.38"/>
                    <measurement group_id="O7" value="14.0" lower_limit="4.38" upper_limit="23.62"/>
                    <measurement group_id="O8" value="19.6" lower_limit="8.10" upper_limit="31.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="10.6" lower_limit="1.82" upper_limit="19.45"/>
                    <measurement group_id="O6" value="19.2" lower_limit="4.08" upper_limit="34.38"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="17.4" lower_limit="6.44" upper_limit="28.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="19.1" lower_limit="7.90" upper_limit="30.40"/>
                    <measurement group_id="O6" value="15.4" lower_limit="1.52" upper_limit="29.25"/>
                    <measurement group_id="O7" value="4.0" lower_limit="0.00" upper_limit="9.43"/>
                    <measurement group_id="O8" value="26.1" lower_limit="13.40" upper_limit="38.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="17.0" lower_limit="6.28" upper_limit="27.77"/>
                    <measurement group_id="O6" value="23.1" lower_limit="6.88" upper_limit="39.27"/>
                    <measurement group_id="O7" value="12.0" lower_limit="2.99" upper_limit="21.01"/>
                    <measurement group_id="O8" value="23.9" lower_limit="11.59" upper_limit="36.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Who Achieved CDAI Remission at Each Visit Based on NRI</title>
        <description>The CDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-76. CDAI score of 22 or above = high disease activity, a value between 10 and 22 = moderate disease activity and value less than or equal to &lt;=10 = low disease activity. Higher scores indicated higher disease activity. CDAI Remission was defined as CDAI score &lt;=2.8. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using NRI.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Who Achieved CDAI Remission at Each Visit Based on NRI</title>
          <description>The CDAI was calculated from tender joint counts of 28, swollen joint counts of 28, participant's global assessment of disease activity, physician global assessment of disease activity score, and CRP value. Total score ranged between 0-76. CDAI score of 22 or above = high disease activity, a value between 10 and 22 = moderate disease activity and value less than or equal to &lt;=10 = low disease activity. Higher scores indicated higher disease activity. CDAI Remission was defined as CDAI score &lt;=2.8. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using NRI.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Remission at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O5" value="2.1" lower_limit="0.00" upper_limit="6.25"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O5" value="2.1" lower_limit="0.00" upper_limit="6.25"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O7" value="2.0" lower_limit="0.00" upper_limit="5.88"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O2" value="7.1" lower_limit="0.00" upper_limit="16.68"/>
                    <measurement group_id="O3" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O4" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O5" value="2.1" lower_limit="0.00" upper_limit="6.25"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="4.0" lower_limit="0.00" upper_limit="9.43"/>
                    <measurement group_id="O8" value="2.2" lower_limit="0.00" upper_limit="6.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O2" value="10.7" lower_limit="0.00" upper_limit="22.17"/>
                    <measurement group_id="O3" value="5.6" lower_limit="0.00" upper_limit="11.67"/>
                    <measurement group_id="O4" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O5" value="4.3" lower_limit="0.00" upper_limit="10.03"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="4.3" lower_limit="0.00" upper_limit="10.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" lower_limit="0.42" upper_limit="14.39"/>
                    <measurement group_id="O2" value="10.7" lower_limit="0.00" upper_limit="22.17"/>
                    <measurement group_id="O3" value="7.4" lower_limit="0.42" upper_limit="14.39"/>
                    <measurement group_id="O4" value="9.3" lower_limit="1.53" upper_limit="16.99"/>
                    <measurement group_id="O5" value="8.5" lower_limit="0.53" upper_limit="16.49"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="10.9" lower_limit="1.87" upper_limit="19.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" lower_limit="0.00" upper_limit="11.67"/>
                    <measurement group_id="O2" value="7.1" lower_limit="0.00" upper_limit="16.68"/>
                    <measurement group_id="O3" value="7.4" lower_limit="0.42" upper_limit="14.39"/>
                    <measurement group_id="O4" value="9.3" lower_limit="1.53" upper_limit="16.99"/>
                    <measurement group_id="O5" value="6.4" lower_limit="0.00" upper_limit="13.37"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="10.9" lower_limit="1.87" upper_limit="19.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="8.5" lower_limit="0.53" upper_limit="16.49"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="10.9" lower_limit="1.87" upper_limit="19.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="6.4" lower_limit="0.00" upper_limit="13.37"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="10.0" lower_limit="1.68" upper_limit="18.32"/>
                    <measurement group_id="O8" value="13.0" lower_limit="3.31" upper_limit="22.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="6.4" lower_limit="0.00" upper_limit="13.37"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O7" value="12.0" lower_limit="2.99" upper_limit="21.01"/>
                    <measurement group_id="O8" value="15.2" lower_limit="4.84" upper_limit="25.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="8.5" lower_limit="0.53" upper_limit="16.49"/>
                    <measurement group_id="O6" value="3.8" lower_limit="0.00" upper_limit="11.24"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="13.0" lower_limit="3.31" upper_limit="22.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="8.5" lower_limit="0.53" upper_limit="16.49"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="16.0" lower_limit="5.84" upper_limit="26.16"/>
                    <measurement group_id="O8" value="15.2" lower_limit="4.84" upper_limit="25.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="17.0" lower_limit="6.28" upper_limit="27.77"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="12.0" lower_limit="2.99" upper_limit="21.01"/>
                    <measurement group_id="O8" value="19.6" lower_limit="8.10" upper_limit="31.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="19.1" lower_limit="7.90" upper_limit="30.40"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="13.0" lower_limit="3.31" upper_limit="22.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="10.6" lower_limit="1.82" upper_limit="19.45"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="17.4" lower_limit="6.44" upper_limit="28.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="12.8" lower_limit="3.23" upper_limit="22.31"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="14.0" lower_limit="4.38" upper_limit="23.62"/>
                    <measurement group_id="O8" value="13.0" lower_limit="3.31" upper_limit="22.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="8.5" lower_limit="0.53" upper_limit="16.49"/>
                    <measurement group_id="O6" value="19.2" lower_limit="4.08" upper_limit="34.38"/>
                    <measurement group_id="O7" value="12.0" lower_limit="2.99" upper_limit="21.01"/>
                    <measurement group_id="O8" value="10.9" lower_limit="1.87" upper_limit="19.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="19.1" lower_limit="7.90" upper_limit="30.40"/>
                    <measurement group_id="O6" value="19.2" lower_limit="4.08" upper_limit="34.38"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="19.6" lower_limit="8.10" upper_limit="31.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="10.6" lower_limit="1.82" upper_limit="19.45"/>
                    <measurement group_id="O6" value="15.4" lower_limit="1.52" upper_limit="29.25"/>
                    <measurement group_id="O7" value="12.0" lower_limit="2.99" upper_limit="21.01"/>
                    <measurement group_id="O8" value="17.4" lower_limit="6.44" upper_limit="28.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="10.6" lower_limit="1.82" upper_limit="19.45"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="19.6" lower_limit="8.10" upper_limit="31.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="19.1" lower_limit="7.90" upper_limit="30.40"/>
                    <measurement group_id="O6" value="15.4" lower_limit="1.52" upper_limit="29.25"/>
                    <measurement group_id="O7" value="2.0" lower_limit="0.00" upper_limit="5.88"/>
                    <measurement group_id="O8" value="23.9" lower_limit="11.59" upper_limit="36.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="14.9" lower_limit="4.72" upper_limit="25.07"/>
                    <measurement group_id="O6" value="23.1" lower_limit="6.88" upper_limit="39.27"/>
                    <measurement group_id="O7" value="10.0" lower_limit="1.68" upper_limit="18.32"/>
                    <measurement group_id="O8" value="23.9" lower_limit="11.59" upper_limit="36.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Who Achieved Boolean Remission at Each Visit Based on NRI</title>
        <description>Boolean remission criteria was defined as: tender joint count 68 &lt;=1; swollen joint count 68 &lt;=1; CRP &lt;=1 mg/dL; and disease activity assessments VAS (mm) by participants &lt;=1. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Weeks 2, 4, 8, 12, 16, 20, and 24; Extension Phase: Weeks 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, and 84</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using NRI.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Who Achieved Boolean Remission at Each Visit Based on NRI</title>
          <description>Boolean remission criteria was defined as: tender joint count 68 &lt;=1; swollen joint count 68 &lt;=1; CRP &lt;=1 mg/dL; and disease activity assessments VAS (mm) by participants &lt;=1. Data reported for the Extension Phase from Week 2 to Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using NRI.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Remission at Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O7" value="2.0" lower_limit="0.00" upper_limit="5.88"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O6" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O7" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O2" value="3.6" lower_limit="0.00" upper_limit="10.45"/>
                    <measurement group_id="O3" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O4" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O5" value="2.1" lower_limit="0.00" upper_limit="6.25"/>
                    <measurement group_id="O6" value="3.8" lower_limit="0.00" upper_limit="11.24"/>
                    <measurement group_id="O7" value="4.0" lower_limit="0.00" upper_limit="9.43"/>
                    <measurement group_id="O8" value="4.3" lower_limit="0.00" upper_limit="10.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O2" value="7.1" lower_limit="0.00" upper_limit="16.68"/>
                    <measurement group_id="O3" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O4" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O5" value="2.1" lower_limit="0.00" upper_limit="6.25"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="4.0" lower_limit="0.00" upper_limit="9.43"/>
                    <measurement group_id="O8" value="4.3" lower_limit="0.00" upper_limit="10.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 20</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O2" value="3.6" lower_limit="0.00" upper_limit="10.45"/>
                    <measurement group_id="O3" value="3.7" lower_limit="0.00" upper_limit="8.74"/>
                    <measurement group_id="O4" value="9.3" lower_limit="1.53" upper_limit="16.99"/>
                    <measurement group_id="O5" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O6" value="3.8" lower_limit="0.00" upper_limit="11.24"/>
                    <measurement group_id="O7" value="4.0" lower_limit="0.00" upper_limit="9.43"/>
                    <measurement group_id="O8" value="10.9" lower_limit="1.87" upper_limit="19.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.00" upper_limit="5.45"/>
                    <measurement group_id="O2" value="3.6" lower_limit="0.00" upper_limit="10.45"/>
                    <measurement group_id="O3" value="5.6" lower_limit="0.00" upper_limit="11.67"/>
                    <measurement group_id="O4" value="5.6" lower_limit="0.00" upper_limit="11.67"/>
                    <measurement group_id="O5" value="2.1" lower_limit="0.00" upper_limit="6.25"/>
                    <measurement group_id="O6" value="3.8" lower_limit="0.00" upper_limit="11.24"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="6.5" lower_limit="0.00" upper_limit="13.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="4.3" lower_limit="0.00" upper_limit="10.03"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="6.5" lower_limit="0.00" upper_limit="13.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 32</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="0.0" lower_limit="0.00" upper_limit="0.00"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="8.7" lower_limit="0.55" upper_limit="16.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="2.1" lower_limit="0.00" upper_limit="6.25"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="10.0" lower_limit="1.68" upper_limit="18.32"/>
                    <measurement group_id="O8" value="8.7" lower_limit="0.55" upper_limit="16.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 40</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="4.3" lower_limit="0.00" upper_limit="10.03"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="4.0" lower_limit="0.00" upper_limit="9.43"/>
                    <measurement group_id="O8" value="8.7" lower_limit="0.55" upper_limit="16.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 44</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="2.1" lower_limit="0.00" upper_limit="6.25"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="14.0" lower_limit="4.38" upper_limit="23.62"/>
                    <measurement group_id="O8" value="8.7" lower_limit="0.55" upper_limit="16.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="4.3" lower_limit="0.00" upper_limit="10.03"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="10.0" lower_limit="1.68" upper_limit="18.32"/>
                    <measurement group_id="O8" value="15.2" lower_limit="4.84" upper_limit="25.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="6.4" lower_limit="0.00" upper_limit="13.37"/>
                    <measurement group_id="O6" value="3.8" lower_limit="0.00" upper_limit="11.24"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="8.7" lower_limit="0.55" upper_limit="16.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="4.3" lower_limit="0.00" upper_limit="10.03"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="10.9" lower_limit="1.87" upper_limit="19.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="6.4" lower_limit="0.00" upper_limit="13.37"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="10.0" lower_limit="1.68" upper_limit="18.32"/>
                    <measurement group_id="O8" value="6.5" lower_limit="0.00" upper_limit="13.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 64</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="10.6" lower_limit="1.82" upper_limit="19.45"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="8.7" lower_limit="0.55" upper_limit="16.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 68</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="10.6" lower_limit="1.82" upper_limit="19.45"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="8.7" lower_limit="0.55" upper_limit="16.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="6.4" lower_limit="0.00" upper_limit="13.37"/>
                    <measurement group_id="O6" value="7.7" lower_limit="0.00" upper_limit="17.93"/>
                    <measurement group_id="O7" value="8.0" lower_limit="0.48" upper_limit="15.52"/>
                    <measurement group_id="O8" value="15.2" lower_limit="4.84" upper_limit="25.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="2.1" lower_limit="0.00" upper_limit="6.25"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="4.0" lower_limit="0.00" upper_limit="9.43"/>
                    <measurement group_id="O8" value="15.2" lower_limit="4.84" upper_limit="25.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 80</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="8.5" lower_limit="0.53" upper_limit="16.49"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="19.6" lower_limit="8.10" upper_limit="31.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remission at Week 84</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="8.5" lower_limit="0.53" upper_limit="16.49"/>
                    <measurement group_id="O6" value="11.5" lower_limit="0.00" upper_limit="23.82"/>
                    <measurement group_id="O7" value="6.0" lower_limit="0.00" upper_limit="12.58"/>
                    <measurement group_id="O8" value="19.6" lower_limit="8.10" upper_limit="31.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Modified Total Sharp Score (mTSS) at Each Visit Based on Observed Cases (OC)</title>
        <description>The mTSS was a measure of change in joint health. X-rays of hands, wrists, and feet (including distal interphalangeal joints) were obtained. Totals for hands and feet for erosion scores (range 0 to 320) and joint space narrowing scores (range 0 to 208) were calculated and added to obtain the mTSS (range = 0 [normal] to 528 [maximal disease]). An increase in mTSS from Baseline represents disease progression and/or joint worsening; no progression was defined as a change of &lt;=0.5. Data reported for the Extension Phase from Baseline and Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
        <time_frame>Treatment Phase: Baseline and Week 24; Extension Phase: Baseline, Weeks 24, 52, 76, and 104</time_frame>
        <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using OC.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Phase: Placebo</title>
            <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O2">
            <title>Treatment Phase: E6011 100 mg</title>
            <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O3">
            <title>Treatment Phase: E6011 200 mg</title>
            <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O4">
            <title>Treatment Phase: E6011 400/200 mg</title>
            <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
          </group>
          <group group_id="O5">
            <title>Extension Phase: Placebo</title>
            <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O6">
            <title>Extension Phase: E6011 100 mg</title>
            <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O7">
            <title>Extension Phase: E6011 200 mg</title>
            <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
          <group group_id="O8">
            <title>Extension Phase: E6011 400/200 mg</title>
            <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Modified Total Sharp Score (mTSS) at Each Visit Based on Observed Cases (OC)</title>
          <description>The mTSS was a measure of change in joint health. X-rays of hands, wrists, and feet (including distal interphalangeal joints) were obtained. Totals for hands and feet for erosion scores (range 0 to 320) and joint space narrowing scores (range 0 to 208) were calculated and added to obtain the mTSS (range = 0 [normal] to 528 [maximal disease]). An increase in mTSS from Baseline represents disease progression and/or joint worsening; no progression was defined as a change of &lt;=0.5. Data reported for the Extension Phase from Baseline and Week 24, is the same data for the Treatment Phase, but excluding the participants who did not gave consent to participate in Extension Phase.</description>
          <population>FAS was the group of randomized participants who received at least 1 dose of study drug and had at least 1 postdose primary efficacy measurement. Here number analyzed &quot;n&quot; are the participants who were evaluable for the outcome measure for given time points. Missing data was imputed using OC.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="54"/>
                <count group_id="O4" value="54"/>
                <count group_id="O5" value="47"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.20" spread="46.948"/>
                    <measurement group_id="O2" value="30.00" spread="36.582"/>
                    <measurement group_id="O3" value="37.55" spread="56.095"/>
                    <measurement group_id="O4" value="27.64" spread="40.621"/>
                    <measurement group_id="O5" value="17.08" spread="25.897"/>
                    <measurement group_id="O6" value="29.11" spread="34.551"/>
                    <measurement group_id="O7" value="31.61" spread="47.092"/>
                    <measurement group_id="O8" value="26.19" spread="35.524"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="28"/>
                    <count group_id="O3" value="54"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.31" spread="2.639"/>
                    <measurement group_id="O2" value="2.54" spread="4.768"/>
                    <measurement group_id="O3" value="1.82" spread="4.075"/>
                    <measurement group_id="O4" value="1.34" spread="3.106"/>
                    <measurement group_id="O5" value="1.01" spread="1.929"/>
                    <measurement group_id="O6" value="1.20" spread="3.092"/>
                    <measurement group_id="O7" value="0.95" spread="3.392"/>
                    <measurement group_id="O8" value="0.49" spread="1.438"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="2.37" spread="4.302"/>
                    <measurement group_id="O6" value="3.11" spread="4.711"/>
                    <measurement group_id="O7" value="3.35" spread="10.366"/>
                    <measurement group_id="O8" value="1.33" spread="3.559"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 76</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="3.00" spread="5.931"/>
                    <measurement group_id="O6" value="3.61" spread="5.631"/>
                    <measurement group_id="O7" value="3.96" spread="14.378"/>
                    <measurement group_id="O8" value="1.63" spread="3.992"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 104</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="47"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="50"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O5" value="3.49" spread="6.643"/>
                    <measurement group_id="O6" value="4.02" spread="5.598"/>
                    <measurement group_id="O7" value="4.70" spread="17.549"/>
                    <measurement group_id="O8" value="1.57" spread="3.885"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From the first dose of study drug up to 104 Weeks (Treatment Phase: From the first dose of study drug till Week 24; Extension Phase: Post Week 24 till Week 104])</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Treatment Phase: Placebo</title>
          <description>During Treatment Phase, participants received E6011-matched placebo, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
        </group>
        <group group_id="E2">
          <title>Treatment Phase: E6011 100 mg</title>
          <description>During Treatment Phase, participants received E6011 100 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
        </group>
        <group group_id="E3">
          <title>Treatment Phase: E6011 200 mg</title>
          <description>During Treatment Phase, participants received E6011 200 mg, infusion, subcutaneously, at Weeks 0, 1, and 2 and then every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
        </group>
        <group group_id="E4">
          <title>Treatment Phase: E6011 400/200 mg</title>
          <description>During Treatment Phase, participants received E6011 400 mg, infusion, subcutaneously, at Weeks 0, 1, 4, 6, 8, 10 and then E6011 200 mg, infusion, subcutaneously, every 2 weeks up to Week 22. Following completion of evaluations of the Treatment Phase at Week 24, participants entered the Extension Phase.</description>
        </group>
        <group group_id="E5">
          <title>Extension Phase: Placebo</title>
          <description>Participants who received E6011-matched placebo and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
        <group group_id="E6">
          <title>Extension Phase: E6011 100 mg</title>
          <description>Participants who received E6011 100 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
        <group group_id="E7">
          <title>Extension Phase: E6011 200 mg</title>
          <description>Participants who received E6011 200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
        <group group_id="E8">
          <title>Extension Phase: E6011 400/200 mg</title>
          <description>Participants who received E6011 400/200 mg and completed evaluations of the Treatment Phase at Week 24, entered the Extension Phase and received E6011 200 mg, infusion, subcutaneously, every 2 weeks until Week 102.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 20.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Vascular stent restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pneumocystis jirovecii pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Extremity contracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Facial paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 20.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="38" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="43" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="46" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="26" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="50" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="45" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Supraventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Eustachian tube dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Ear discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Deafness neurosensory</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Autoimmune thyroiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Corneal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Eye discharge</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Eyelid oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Lacrimation increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Vitreous floaters</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Asthenopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Blepharitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Ocular hyperaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Cataract subcapsular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Conjunctivitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Eye pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Metamorphopsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dacryostenosis acquired</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Tooth loss</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Mouth haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Cheilitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Faeces soft</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Leukoplakia oral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Lip ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Periodontal disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Gastrointestinal motility disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Injection site bruising</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Injection site reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Injection site pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Injection site rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Drug-induced liver injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy to arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="18" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="28" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="15" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="30" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="28" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Angular cheilitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Enteritis infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Gingivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pneumonia pneumococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Gingival abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Tinea pedis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dermatophytosis of nail</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Bacterial vulvovaginitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Body tinea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Helicobacter gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Herpes simplex</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pulpitis dental</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis mycoplasmal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Vulvovaginal mycotic infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dacryocystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Eyelid folliculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Onychomycosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Chillblains</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Mouth injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Nasal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Tooth fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Animal scratch</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dislocation of vertebra</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Iliotibial band syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Lip injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Cell marker increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Lymphocyte count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Blood alkaline phosphatase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Blood uric acid increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>C-reactive protein increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>CD4 lymphocytes decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Fibrin D dimer increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Liver function test increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Low density lipoprotein increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Procalcitonin increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>White blood cell count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Chest X-ray abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Human chorionic gonadotropin increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Mycobacterium tuberculosis complex test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Blood triglycerides increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Double stranded DNA antibody positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Plantar fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Rheumatoid nodule</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Chondrocalcinosis pyrophosphate</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Nodal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Atlantoaxial instability</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Skin papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of thyroid gland</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Haemangioma of liver</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Lymphoproliferative disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pyogenic granuloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Vagus nerve disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dyslalia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Essential tremor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Intercostal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Peroneal nerve palsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Somatic symptom disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Bulimia nervosa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertonic bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pelvi-ureteric obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Breast cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Eczema asteatotic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Haemorrhage subcutaneous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Hyperkeratosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Ingrowing nail</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Miliaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Henoch-Schonlein purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Pustular psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Asteatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Prurigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Solar lentigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Internal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Inquiry Service</name_or_title>
      <organization>Eisai Co., Ltd.</organization>
      <email>eisai-chiken_hotline@hhc.eisai.co.jp</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

